0001214659-23-007091.txt : 20230515 0001214659-23-007091.hdr.sgml : 20230515 20230515124526 ACCESSION NUMBER: 0001214659-23-007091 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 45 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Electronic Servitor Publication Network Inc. CENTRAL INDEX KEY: 0001709542 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 821873116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55809 FILM NUMBER: 23920296 BUSINESS ADDRESS: STREET 1: 400 1ST AVE N., STREET 2: STE. 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55401 BUSINESS PHONE: 612-688-1407 MAIL ADDRESS: STREET 1: 400 1ST AVE N., STREET 2: STE. 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55401 FORMER COMPANY: FORMER CONFORMED NAME: CannAssist International Corp DATE OF NAME CHANGE: 20180523 FORMER COMPANY: FORMER CONFORMED NAME: Iris Grove Acquisition Corp DATE OF NAME CHANGE: 20170616 10-Q 1 j5923110q.htm
0001709542 false 2023 Q1 --12-31 0001709542 2023-01-01 2023-03-31 0001709542 2023-05-09 0001709542 2023-03-31 0001709542 2022-12-31 0001709542 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001709542 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001709542 2022-01-01 2022-03-30 0001709542 us-gaap:PreferredStockMember 2022-12-31 0001709542 us-gaap:CommonStockMember 2022-12-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001709542 us-gaap:RetainedEarningsMember 2022-12-31 0001709542 us-gaap:PreferredStockMember 2021-12-31 0001709542 us-gaap:CommonStockMember 2021-12-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001709542 us-gaap:RetainedEarningsMember 2021-12-31 0001709542 2021-12-31 0001709542 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001709542 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001709542 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001709542 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001709542 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001709542 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001709542 2022-01-01 2022-03-31 0001709542 us-gaap:PreferredStockMember 2023-03-31 0001709542 us-gaap:CommonStockMember 2023-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001709542 us-gaap:RetainedEarningsMember 2023-03-31 0001709542 us-gaap:PreferredStockMember 2022-03-31 0001709542 us-gaap:CommonStockMember 2022-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001709542 us-gaap:RetainedEarningsMember 2022-03-31 0001709542 2022-03-31 0001709542 2022-03-30 0001709542 srt:ChiefExecutiveOfficerMember 2021-06-28 2021-07-01 0001709542 xesp:PhitechManagementLLCMember 2021-07-20 2021-07-23 0001709542 xesp:PhitechManagementLLCMember 2021-07-23 0001709542 2021-10-07 2021-10-09 0001709542 2021-10-09 0001709542 xesp:ThirdParty1Member 2022-05-19 0001709542 xesp:ThirdParty1Member 2022-05-01 2022-05-19 0001709542 xesp:ThirdParty1Member 2023-03-31 0001709542 xesp:ThirdParty2Member 2022-05-20 0001709542 xesp:ThirdParty2Member 2022-05-01 2022-05-20 0001709542 xesp:ThirdParty2Member 2023-03-31 0001709542 xesp:ThirdParty3Member 2022-06-10 0001709542 xesp:ThirdParty3Member 2022-06-01 2022-06-10 0001709542 xesp:ThirdParty3Member 2023-03-31 0001709542 xesp:ThirdParty4Member 2022-10-18 0001709542 xesp:ThirdParty4Member 2022-10-01 2022-10-18 0001709542 xesp:ThirdParty4Member 2023-03-31 0001709542 xesp:ThirdParty5Member 2023-01-06 0001709542 xesp:ThirdParty5Member 2023-01-01 2023-01-06 0001709542 xesp:ThirdParty5Member 2023-03-31 0001709542 xesp:ThirdParty6Member 2023-03-13 0001709542 xesp:ThirdParty6Member 2023-03-01 2023-03-13 0001709542 xesp:ThirdParty6Member 2023-03-31 0001709542 xesp:Forty7SelectHoldingsLLCMember 2022-12-31 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-03-31 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-01-10 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-01-01 2023-01-10 0001709542 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001709542 xesp:OptionsMember 2023-03-31 0001709542 xesp:OptionsMember 2023-01-01 2023-03-31 0001709542 2022-01-01 2022-12-31 0001709542 srt:MinimumMember us-gaap:OptionMember 2023-03-31 0001709542 srt:MaximumMember us-gaap:OptionMember 2023-03-31 0001709542 us-gaap:OptionMember 2023-03-31 0001709542 us-gaap:WarrantMember 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

 

x   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

 

ACT OF 1934

 

For the quarterly period ended MARCH 31, 2023

 

  ¨   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

 

Commission file number:  000-55809

 

ELECTRONIC SERVITOR PUBLICATION NETWORK INC.

 (Exact name of registrant as specified in its charter)

 

Delaware   82-1873116
(State or Other Jurisdiction of Incorporation or
Organization)
  (I.R.S. Employer Identification No.)
     

400 1ST AVE N., STE. 100

MINNEAPOLIS MN 55401

  55401
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (833) 991-0800

  

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days).    Yes  x    No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 

Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
       
Non-accelerated filer x Smaller Reporting Company x
       
    Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(1) of the Exchange Act. ¨

 

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No x  

  

As of May 9, 2023, the Company had 21,416,001 shares of its common stock, par value $.0001 per share, issued and outstanding.

 

 

 

   
 

 

TABLE OF CONTENTS

 

PART I    
     
Item 1. Condensed Unaudited Financial Statements 3
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 13
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 15
     
Item 4. Controls and Procedures 15
     
PART II    
     
Item 1. Legal Proceedings 16
     
Item 1A. Risk Factors 16
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 16
     
Item 3. Defaults Upon Senior Securities 17
     
Item 4. Mining Safety Disclosures 17
     
Item 5. Other Information 17
     
Item 6. Exhibits 17
     
  Signatures 18

 

 2 
 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

 

ELECTRONIC SERVITOR PUBLICATION NETWORK INC.

INDEX TO FINANCIAL STATEMENTS

 

 

Balance Sheets as of March 31, 2023 (unaudited) and December 31, 2022 4
   
Statements of Operations for the three months ended March 31, 2023 and 2022 (unaudited) 5
   
Statements of Changes in Stockholders’ Equity (Deficit) for the three months ended March 31, 2023 and 2022 (unaudited) 6
   
Statements of Cash Flows for the three months ended March 31, 2023 and 2022 (unaudited) 7
   
Notes to Financial Statements (unaudited) 8

 

 3 
 

 

ELECTRONIC SERVITOR PUBLICATION NETWORK, INC.

BALANCE SHEETS

 

           
   March 31,
2023
   December 31,
 2022
 
   (Unaudited)     
ASSETS        
Current assets:        
Cash  $8,812   $17,139 
Prepaid   3,990     
           
Total assets  $12,802   $17,139 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable and accruals  $51,517   $49,680 
Loans payable   79,630    52,630 
Due to a related party   65,268    50,268 
Total current liabilities   196,415    152,578 
           
Commitments and contingencies        
           
Stockholders’ Deficit:          
Preferred stock, $0.0001 par value 19,999,000 shares
authorized; no shares issued and outstanding
        
Series A Preferred stock, $0.0001 par value 1,000 shares
authorized; 1,000 shares issued and outstanding
        
Common Stock, $0.0001 par value, 100,000,000 shares
authorized; 21,416,001 shares issued and
outstanding
   2,142    2,142 
Additional paid in capital   6,444,055    6,224,900 
Accumulated deficit   (6,629,810)   (6,362,481)
Total Stockholders’ deficit   (183,613)   (135,439)
           
Total Liabilities and Stockholders’ Deficit  $12,802   $17,139 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 4 
 

 

ELECTRONIC SERVITOR PUBLICATION NETWORK, INC.

STATEMENTS OF OPERATIONS
(Unaudited)

 

           
   For the Three Months Ended
March 31,
 
   2023   2022 
Operating expenses:        
General and administrative  $10,225   $1,659 
Professional fees   35,021    25,000 
Stock based compensation   219,155    97,435 
Total operating expenses   264,401    124,094 
           
Loss from operations   (264,401)   (124,094)
           
Other expense:          
Interest expense   (2,928)    
Total other expense   (2,928)    
           
Loss before provision for income taxes   (267,329)   (124,094)
Provision for income taxes        
           
 Net loss  $(267,329)  $(124,094)
           
Loss per share, basic and diluted  $(0.01)  $(0.01)
           
Weighted average shares outstanding, basic
and diluted
   21,416,001    21,416,001 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 5 
 

 

ELECTRONIC SERVITOR PUBLICATION NETWORK, INC.

STATEMENTS OF CHANGES OF STOCKHOLDERS’ DEFICIT

For the Three Months Ended March 31, 2023 and 2022

(Unaudited)

 

                                    
                   Additional       Total 
   Preferred Stock   Common Stock   Paid-in   Accumulated   Stockholders' 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2022   1,000   $    21,416,001   $2,142   $6,224,900   $(6,362,481)  $(135,439)
Stock option expense                   219,155        219,155 
Net loss                       (267,329)   (267,329)
Balance, March 31, 2023   1,000   $    21,416,001   $2,142   $6,444,055   $(6,629,810)  $(183,613)

 

 

                   Additional       Total 
   Preferred Stock   Common Stock   Paid-in   Accumulated   Stockholders' 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2021   1,000   $    21,416,001   $2,143   $5,876,611   $(5,915,232)  $(36,478)
Warrant expense                   97,435        97,435 
Net loss                       (124,094)   (124,094)
Balance, March 31, 2022   1,000   $    21,416,001   $2,143   $5,974,046   $(6,039,326)  $(63,137)

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 6 
 

 

ELECTRONIC SERVITOR PUBLICATION NETWORK, INC.

STATEMENTS OF CASH FLOWS

(Unaudited)

 
           
   For the Three Months Ended
March 31,
 
   2023   2022 
Cash flows from operating activities:        
Net loss  $(267,329)  $(124,094)
Adjustments to reconcile net loss to net cash
used in operating activities:
          
Stock based compensation   219,155    97,435 
Changes in Operating Assets and Liabilities:          
Prepaid   (3,990)    
Accounts payable and accruals   1,837    11,617 
Net cash used by operating activities   (50,327)   (15,042)
           
Cash flows from Investing activities:        
           
Cash flows from Financing activities:          
Proceeds from loans - related party   15,000    19,643 
Proceeds from loans payable   27,000     
Net cash provided by financing activities   42,000    19,643 
           
Net change in cash   (8,327)   4,601 
Cash, beginning of period   17,139     
Cash, end of period  $8,812   $4,601 
           
Cash Paid For:          
Cash paid for interest  $   $ 
Cash paid for taxes  $   $ 
           
Supplemental disclosure of non-cash activity:          
Conversion of debt  $   $14,500 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 7 
 

 

ELECTRONIC SERVITOR PUBLICATION NETWORK, INC.

NOTES TO UNAUDITED FINANCIAL STATEMENTS

MARCH 31, 2023

 

 NOTE 1 - DESCRIPTION OF BUSINESS AND HISTORY

 

Description of business

 

The Company was originally incorporated on May 17, 2017, under the laws of the State of Delaware to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions. On May 23, 2018, the Certificate of Incorporation of the Company was amended to effect a change in the Company’s name from “Iris Grove Acquisition Corporation” to “CannAssist International Corporation”. On September 28, 2021, the Certificate of Incorporation of the Company was amended a second time to effect a change in the Company’s name from “CannAssist International Corporation” to the name “Electronic Servitor Publication Network, Inc.” The Company’s common stock trades on the OTCQB Venture Market under the stock ticker symbol “XESP,” previously from “CNSC,” effective January 26, 2022. The Company's corporate office is located at 400 1ST Ave N., Ste. 100, Minneapolis, MN 55401. The URL of the Company’s website is https://www.xespn.com. The Company’s telephone number is (833) 991-0800.

 

The Company’s business focuses on driving growth for Brands through effective digital interactions within current and new communities. The Company’s proprietary technology, the Digital Engagement Engine, utilizes a combination of automation, unique data management, and a modern workflow built on a microservices architecture to achieve greater reach and lift for content providers.

 

On July 1, 2021, and effective on October 9, 2021, Mark Palumbo, a former officer and director of the Company, and Forty 7 Select Holdings LLC, an entity controlled by Greg Shockey (who was an existing shareholder of the Company), entered into an agreement pursuant to which Mark Palumbo transferred all of his 1,000 shares of Series A Preferred Stock (representing 100% of the Company’s issued and outstanding Series A Preferred Stock), of the Company to Forty 7 Select Holdings LLC in a private transaction. The Series A Preferred Stock provides the holder thereof the right to vote 60% of the Company’s voting shares on any and all shareholder matters and thereby constituted a change of control of the Company. Further, Mark Palumbo contributed 7,500,000 shares of common stock held by him to the treasury of the Company for cancellation at no cost (the “Contribution”).

 

On July 23, 2021, the Company entered into a Technology License Agreement with Phitech Management, LLC, an entity controlled by Peter Hager (“Licensor”), to use, market, promote and distribute certain technology relating to content provisioning including the related patent applications, trade-secrets and associated knowhow, including methods, techniques, specifications, procedures, information, systems, knowledge and business processes required to practice and carry on business in the field of data collection, security and management (the “Technology”). The initial term of the License is 10-years (the “Initial Term”) and shall automatically be renewed for successive 1-year terms (each, a “Renewal Term”) unless the Company elects to terminate the License by giving 30 days’ written notice prior to commencement of a Renewal Term. In exchange for the License of the Technology, the Company issues to the Licensor 10,000,000 restricted shares of its common stock (which is an amount equal to $2,500,000 divided by $0.25, which was the closing market price of the Company’s common stock on the trading day prior to the effective date of the License Agreement). On October 9, 2021, at the Closing of the Technology License Agreement, the Company received the License to the Technology and issued Licensor 10,000,000 restricted shares of the Company’s common stock, at a cost basis of $0.25 per share.

 

On July 23, 2021, the Company and Mark Palumbo entered into an agreement (the “Spin-Off Agreement”) whereby, at the Closing, the Company shall transfer 100% of the issued and outstanding membership units of Xceptor LLC, an entity that was a wholly-owned subsidiary of the Company, to Mark Palumbo (along with the assets and liabilities associated with the prior business) for nominal consideration as a condition of the Change-in-Control (the “Spin-Off”). Furthermore, at the Closing, that certain Technology License Agreement entered into by and between the Company and Mark Palumbo dated April 29, 2019 (the “Palumbo License Agreement”) shall be terminated and the Company shall assign all rights to the underlying Intellectual Property (as defined in the Palumbo License Agreement) to Mark Palumbo. On October 9, 2021, at the Closing of the Spin-Off Agreement, the Company transferred 100% of the issued and outstanding membership units of Xceptor LLC to Mark Palumbo (along with the assets and liabilities associated with the prior business) in exchange for nominal consideration, and the Palumbo License Agreement was terminated.

 

As a result of the transactions described above, the Company is strategically aligning its business to support its mission in becoming the premier content management and distribution platform for content providers in the global markets through the Company’s continued development and acquisitions of publication and monetization products, services, and technologies.

 

 8 
 

 

Effective October 9, 2021, as a result of the transactions described above, the business of the Company changed to focus on Electronic Sports Gaming technology and the development of related infrastructure, specifically the development and commercialization of a technology platform specifically designed for the Electronic Sports and Electronic Gaming markets. The platform will provide an omni-channel publishing tool, with talent identity protection and monetization tools provided in line with interaction and media creation services. Further publication and monetization products and services will be developed and acquired to support these efforts.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Company’s unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the three month period ending March 31, 2023 and not necessarily indicative of the results to be expected for the full year ending December 31, 2023. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentrations of Credit Risk

 

We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).

 

Cash equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents for the periods ended March 31, 2023 and December 31, 2022.

 

Recently issued accounting pronouncements

 

The Company has implemented all new applicable accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

NOTE 3 - GOING CONCERN

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has no current source of revenue and an accumulated deficit of $6,629,810 as of March 31, 2023. The Company’s continuation as a going concern is dependent upon its ability to generate revenue to satisfy its obligations on a timely basis and ultimately to attain profitability. There is no guarantee that the Company’s activities will generate sufficient revenues to sustain its operations, or its ability to sell its services to generate consistent profitability. In order to maintain operations, the Company may have to raise additional capital from equity financing and/or from its officers, directors, or principal stockholders, subject to terms obtainable and satisfactory to the Company. There is no guarantee that the Company will be able to raise additional funds or to do so at an advantageous price. The financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

 

NOTE 4 - NOTES PAYABLE

 

On May 19, 2022, the Company issued a note payable for $10,000 to a third party. The note matures in one year and bears interest at 6% per annum. As of March 31, 2023, there is $519 of interest accrued on this note.

 

 9 
 

 

On May 20, 2022, the Company issued a note payable for $10,000 to a third party. The note matures in one year and bears interest at 6% per annum. As of March 31, 2023, there is $518 of interest accrued on this note.

 

On June 10, 2022, the Company issued a note payable for $7,630 to a third party. The note matures in 6 months and bears interest at 10% per annum. As of March 31, 2023, there is $615 of interest accrued on this note.

 

On October 18, 2022, the Company issued a note payable for $25,000 to a third party. The note matures in one year and bears interest at 8% per annum. As of March 31, 2023, there is $899 of interest accrued on this note.

 

On January 6, 2023, the Company issued a note payable for $15,000 to a third party. The note matures on July 6, 2023, and bears interest at 8.5% per annum. As of March 31, 2023, there is $293 of interest accrued on this note.

 

On March 13, 2023, the Company issued a note payable for $12,000 to a third party. The note matures on September 13, 2023, and bears interest at 8.5% per annum. As of March 31, 2023, there is $50 of interest accrued on this note.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

During the year ended December 31, 2022, Forty 7 Select Holdings LLC (“Forty 7”) advanced the Company $27,643, to pay for general operating expenses. Forty 7 is controlled by Greg Shockey, an existing shareholder of the Company. As of March 31, 2023, the balance due to Forty 7 is $50,268.

 

On January 10, 2023, the Company issued a note payable for $15,000 to Forty 7. The note matures on July 10, 2023, and bears interest at 8.5% per annum. As of March 31, 2023, there is $279 of interest accrued on this note.

 

Refer to Note 7 for options to purchase shares of common stock issued to related parties.

 

NOTE 6 – PREFERRED STOCK

 

The Company has designated 1,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock have a par value of $0.0001 per share. The Series A Preferred Shares do not have a dividend rate or liquidation preference and are not convertible into shares of common stock. Series A Preferred Stock, voting together as a class, have the right to vote 60% of the Company’s voting shares on any and all shareholder matters (the “Majority Voting Rights”). Additionally, the Company shall not adopt any amendments to the Company’s Bylaws, Articles of Incorporation, as amended, make any changes to the Certificate of Designations establishing the Series A Preferred Stock, or effect any reclassification of the Series A Preferred Stock, without the affirmative vote of at least a majority of the outstanding shares of Series A Preferred Stock. However, the Company may, by any means authorized by law and without any vote of the holders of shares of Series A Preferred Stock, make technical, corrective, administrative or similar changes to such Certificate of Designations that do not, individually or in the aggregate, adversely affect the rights or preferences of the holders of shares of Series A Preferred Stock. Other than the Majority Voting Rights, the Series A Preferred Stock does not have any other dividend, liquidation, conversion, or redemption rights, whatsoever.

 

NOTE 7 – OPTIONS

 

In the first quarter of 2022, the Company entered into an Employment Agreement with Thomas Spruce, an officer and director of the Company. This Employment Agreement has a term of 2 years and automatically renews for an additional 6-month term unless terminated earlier. This agreement is terminable by each of the parties upon written notice. Under this Employment Agreement, the Company pays a base salary of $1.00 per year and issued options to purchase 500,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of two years and expire 10 years from the date of grant.

 

Effective April 12, 2022, the Company entered into an Advisory Agreement with Greg Shockey, an affiliate of the Company and service provider. Under this Advisory Agreement, the Company issued options to purchase 240,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant.

 

Effective April 12, 2022, the Company entered into an Advisory Agreement with Danijella Dragas, a third-party service provider. Under this Advisory Agreement, the Company issued options to purchase 240,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant. On March 23, 2023, the Advisory Agreement was cancelled, thereby terminating Danijella Dragas and forfeiting 60,000 unvested options.

 

 10 
 

 

On May 27, 2022, the Company entered into an Addendum to Employment Agreement with Thomas Spruce, which granted Mr. Spruce options to purchase an additional 250,000 restricted shares of the Company’s common stock at a strike price of $0.15 per share. The options vest immediately from the date of the grant and expire 10 years from the date of grant.

 

On November 16, 2022, the Company entered into an Employment Agreement with Jim Kellogg, which granted Mr. Kellogg options to purchase 300,000 restricted shares of the Company’s common stock at a strike price of $0.10 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant.

 

On February 1, 2023, the Company entered into an Advisor Agreement with Greg Shockey, which supersedes his previous Advisor Agreement with the Company, whereby, in exchange for business development and strategy consulting, investor relations, and facilitating meetings with targeted investors, as well as other services, the Company agreed to issue Greg Shockey options to purchase 60,000 restricted shares of common stock at signing and an additional 1,200,000 shares of restricted common stock every year thereafter for three years.

 

On February 1, 2023, Peter Hager was appointed as the Company’s President and Chief Executive Officer. Per the terms of the employment agreement Mr. Hager was granted options to purchase 6,400,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $0.06 per share, vesting in installments of 500,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and 1,000,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service.

 

On February 1, 2033, Thomas Spruce was appointed as the Company’s Secretary and Chief Operations Officer. Per the terms of the employment agreement Mr. Spruce was granted options to purchase 1,750,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $0.06 per share, vesting with respect to the first 250,000 shares on February 1, 2023 and vesting with respect to the remaining 1,500,000 shares in installments of 125,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and 250,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service.

     

Options issued in the three months ended March 31, 2023, with the following inputs:

Options   11,810,000 
Share price  $0.066 
Exercise Price  $0.06 
Term   10 years 
Volatility   209.39%
Risk Free Interest Rate   3.39%
Dividend rate    

 

A summary of the status of the Company’s outstanding stock options and changes during the year is presented below:

                    
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
Term
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021      $       $ 
Granted   2,030,000   $0.36    10   $ 
Cancelled   (250,000)  $       $ 
Exercised      $       $ 
Outstanding at December 31, 2022   1,780,000   $0.35    9.81   $ 
Granted   11,810,000   $0.06    10   $ 
Cancelled   (60,000)  $       $ 
Exercised      $       $ 
Outstanding at March 31, 2023   13,530,000   $0.09    9.75   $ 
Exercisable at March 31, 2023   2,220,000   $0.24    9.34   $ 

 

           
Range of Exercise
Prices
  Number Outstanding
3/31/2023
  Weighted Average
Remaining
Contractual Life
  Weighted Average
Exercise Price
$0.060.39   13,590,000   9.75 years   $0.09

 

 11 
 

 

NOTE 8 – WARRANTS

 

A summary of the status of the Company’s outstanding stock warrants and changes during the year is presented below:

Schedule of common stock outstanding roll forward                    
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
Term
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021   153,503   $0.25    6.92   $ 
Granted      $       $ 
Expired      $       $ 
Exercised      $       $ 
Outstanding at December 31, 2022   153,503   $0.25    5.92   $ 
Granted      $       $ 
Expired      $       $ 
Exercised      $       $ 
Exercisable at March 31, 2023   153,503   $0.25    5.67   $ 

 

           
Range of Exercise
Prices
  Number Outstanding
3/31/2023
  Weighted Average
Remaining
Contractual Life
  Weighted Average
Exercise Price
$0.25   153,503   5.67 years   $0.25

 

 

NOTE 9 – SUBSEQUENT EVENTS

 

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were issued and has determined that there are no material subsequent events to disclose in these financial statements.

 

 12 
 

 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following information should be read in conjunction with our financial statements and related notes thereto included in Part I, Item 1, above.

 

Forward Looking Statements

 

Certain matters discussed herein are forward-looking statements. Such forward-looking statements contained in this Form 10-Q involve risks and uncertainties, including statements as to:

 

·our future strategic plans

·our future operating results;

·our business prospects;

·our contractual arrangements and relationships with third parties;

·the dependence of our future success on the general economy;

·our possible future financings; and

·the adequacy of our cash resources and working capital.

 

These forward-looking statements can generally be identified as such because the context of the statement will include words such as we “believe,” “anticipate,” “expect,” “estimate” or words of similar meaning. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which are described in close proximity to such statements and which could cause actual results to differ materially from those anticipated. Shareholders, potential investors and other readers are urged to consider these factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included herein are only made as of the date of this Form 10-Q, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

 

Executive Overview

 

The Company was originally incorporated on May 17, 2017, under the laws of the State of Delaware to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions. On May 23, 2018, the Certificate of Incorporation of the Company was amended to effect a change in the Company’s name from “Iris Grove Acquisition Corporation” to “CannAssist International Corporation”. On September 28, 2021, the Certificate of Incorporation of the Company was amended a second time to effect a change in the Company’s name from “CannAssist International Corporation” to the name “Electronic Servitor Publication Network, Inc.”

 

The Company's corporate office is located at 400 1ST Ave N., Ste. 100, Minneapolis, MN 55401. The URL of the Company’s website is https://www.xespn.com. The Company’s telephone number is (833) 991-0800.

 

The Company’s common stock trades on the OTCQB Venture Market under the stock ticker symbol “XESP.”

 

On July 1, 2021, and effective on October 9, 2021, Mark Palumbo, a former officer and director of the Company, and Forty 7 Select Holdings LLC, an entity controlled by Greg Shockey (who was an existing shareholder of the Company), entered into an agreement pursuant to which Mark Palumbo transferred all of his 1,000 shares of Series A Preferred Stock (representing 100% of the Company’s issued and outstanding Series A Preferred Stock), of the Company to Forty 7 Select Holdings LLC in a private transaction. The Series A Preferred Stock provides the holder thereof the right to vote 60% of the Company’s voting shares on any and all shareholder matters and thereby constituted a change of control of the Company. Further, Mark Palumbo contributed 7,500,000 shares of common stock held by him to the treasury of the Company for cancellation at no cost (the “Contribution”). 

 

On July 23, 2021, the Company entered into a Technology License Agreement with Phitech Management, LLC, an entity controlled by Peter Hager (“Licensor”), to use, market, promote and distribute certain technology relating to content provisioning including the related patent applications, trade-secrets and associated knowhow, including methods, techniques, specifications, procedures, information, systems, knowledge and business processes required to practice and carry on business in the field of data collection, security and management (the “Technology”). The initial term of the License is 10-years (the “Initial Term”) and shall automatically be renewed for successive 1-year terms (each, a “Renewal Term”) unless the Company elects to terminate the License by giving 30 days’ written notice prior to commencement of a Renewal Term. In exchange for the License of the Technology, the Company issues to the Licensor 10,000,000 restricted shares of its common stock (which is an amount equal to $2,500,000 divided by $0.25, which was the closing market price of the Company’s common stock on the trading day prior to the effective date of the License Agreement). On October 9, 2021, at the Closing of the Technology License Agreement, the Company received the License to the Technology and issued Licensor 10,000,000 restricted shares of the Company’s common stock, at a cost basis of $0.25 per share.

 

 13 
 

 

On July 23, 2021, the Company and Mark Palumbo entered into an agreement (the “Spin-Off Agreement”) whereby, at the Closing, the Company shall transfer 100% of the issued and outstanding membership units of Xceptor LLC, an entity that was a wholly-owned subsidiary of the Company, to Mark Palumbo (along with the assets and liabilities associated with the prior business) for nominal consideration as a condition of the Change-in-Control (the “Spin-Off”). Furthermore, at the Closing, that certain Technology License Agreement entered into by and between the Company and Mark Palumbo dated April 29, 2019 (the “Palumbo License Agreement”) shall be terminated and the Company shall assign all rights to the underlying Intellectual Property (as defined in the Palumbo License Agreement) to Mark Palumbo. On October 9, 2021, at the Closing of the Spin-Off Agreement, the Company transferred 100% of the issued and outstanding membership units of Xceptor LLC to Mark Palumbo (along with the assets and liabilities associated with the prior business) in exchange for nominal consideration, and the Palumbo License Agreement was terminated.

 

The Company anticipates that it would need approximately $1,500,000 over the next 12 months to continue as a going concern, satisfy its capital commitments and continue its operations in accordance with its current business plan. In addition to revenues generated from sales, the Chief Executive Officer and several shareholders may fund the Company’s operations, if needed, during the next 12 months or until the Company can generate an ongoing source of capital sufficient to independently continue its operations.

 

Although the Company is no longer classified as a development-stage company, it has limited operating history and is expected to experience losses in the near term. The Company’s independent auditors have issued a report raising substantial doubt about the Company’s ability to continue as a going concern.

 

Results of Operation for the Three Months Ended March 31, 2023 and 2022

 

For the three months ended March 31, 2023, the Company had revenues of $0. In comparison, for the three months ended March 31, 2022, the Company had revenues of $0.

 

Operating expenses were $264,401 for the three months ended March 31, 2023. Operating expenses include $10,225 of general and administrative expense, $35,021 of professional fees, and $219,155 of non-cash stock-based compensation expense. In comparison, for the three months ended March 31, 2022, operating expenses were $124,094, including $1,659 of general and administrative expense, $25,000 of professional fees, and $97,435 of non-cash stock-based compensation expense for the issuance of warrants.

 

For the three months ended March 31, 2023, the Company posted a net loss of $264,401, compared to a net loss of $124,094 for three months ended March 31, 2022.

 

During the three months ended March 31, 2023, the Company used $50,327 of cash in operating activities and generated $42,000 in cash from financing activities, and the Company did not use or generate any cash in investing activities. In comparison, for the three months ended March 31, 2022, the Company used $15,042 of cash in operating activities and generated $19,643 in cash from financing activities, and the Company did not use or generate any cash in investing activities.

 

Liquidity and Capital Resources

 

The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has generated revenues of $0 during the three months ended March 31, 2023 and had a net loss of $264,401 for the three months ended March 31, 2023. The Company has an accumulated deficit of $6,629,810 as of March 31, 2023. The Company requires capital for its contemplated operational and marketing activities. The obtainment of additional financing, through an additional capital raise, the successful development of the Company’s contemplated plan of operations, and its transition to the attainment of continued profitable operations are necessary for the Company to continue operations.

 

The Company used $50,327 of cash from operations for the three months ended March 31, 2023. Net cash provided by financing activities for the three months ended March 31, 2023 was $42,000.

 

As of March 31, 2023, the Company had $8,812 in cash.

 

Critical Accounting Estimates and Policies

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Note 2 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes.  Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

 

 14 
 

 

We are subject to various loss contingencies arising in the ordinary course of business.  We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies.  An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired, or a liability has been incurred and the amount of the loss can be reasonably estimated.  We regularly evaluate current information available to us to determine whether such accruals should be adjusted.

 

Off-Balance Sheet Arrangements 

 

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

 

Recent Accounting Pronouncements

 

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure. Management evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, they concluded that our disclosure controls and procedures are designed at a reasonable assurance level and are effective for the quarterly period ended March 31, 2023.

 

Changes in Internal Control over Financial Reporting

 

During the three months ended March 31, 2023, the Company implemented changes to its internal controls to remediate potential material weaknesses pertaining to the following aspects: timely and accurate reconciliation of accounts and lack of segregation of duties. These changes included hiring Peter Hager as the Company’s Chief Executive Officer and instituting processes whereby Jim Kellogg, the Company’s Chief Financial Officer, can oversee internal controls. There have been no other changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. 

 

 15 
 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

On November 4, 2021, a lawsuit captioned CAMRON ELIZABETH v. MARK PALUMBO et al., Case No. CVPS2106116 was filed in the Superior Court of California, County of Riverside against the Company and certain of the former company’s (CannAssist International Corp.) executive officers (collectively, the “Defendants”). The Plaintiff and the former company (CannAssist International Corp.) entered into a Consulting Agreement dated November 20, 2020 (the “Consulting Agreement”), pursuant to which Plaintiff was engaged to provide certain sales and marketing services to that Company. As a condition of this Consulting Agreement, Plaintiff was paid a monthly fee and was granted restricted shares of the common stock of the former company that were subject to certain vesting conditions tied to Plaintiff’s service under the Consulting Agreement. The Consulting Agreement also contained provisions that enabled the former company to terminate the Consulting Agreement without cause after 10 days’ written notice. In September 2021, the former company exercised its right to terminate the Consulting Agreement because management of the former company at the time of termination was dissatisfied with the quality of Plaintiff’s services under the Consulting Agreement. Specifically, management of the former company at the time of termination received complaints from third parties that Plaintiff behaved inappropriately in meetings where Plaintiff made presentations to potential clients and vendors on behalf of the former company. In contrast, Plaintiff alleges, among other things, that the Defendants improperly misclassified Plaintiff as an independent contractor, that certain of the former company’s executive officers committed sexual harassment and defamation and that Defendants unlawfully terminated Plaintiff. A jury trial has been set for May 26, 2023. The Company believes it should not be a party to the lawsuit since the former company, including its operations, officers, employees, contractors, assets, and liabilities were all spun out as part of or as a result of the Spin Out Agreement dated July 23, 2021, and the Plaintiff never contracted with or was employed by the current Company. The Company believes that the lawsuit is without merit and intends to defend the lawsuit vigorously; however, there can be no assurance regarding the ultimate outcome of this lawsuit.

 

Other than as described above, we know of no other material, existing or pending legal proceedings against the Company, nor is it involved as a plaintiff in any material proceeding or pending litigation. Other than as described above, we know of no other proceedings in which our directors, officers or any affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 

ITEM 1A. RISK FACTORS.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

In the first quarter of 2022, the Company entered into an Employment Agreement with Thomas Spruce, an officer and sole director of the Company. Under this Employment Agreement, the Company issued options to purchase 500,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of 1.5 years contingent upon service and have an expiry date of 10 years from the date of grant. In the first quarter of 2023, the Company entered into a new Employment Agreement with Mr. Spruce. Under this new Employment Agreement, the Company issued options to purchase 1,750,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $0.06 per share, vesting with respect to the first 250,000 shares on February 1, 2023 and vesting with respect to the remaining 1,500,000 shares in installments of 125,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and 250,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service. The options have an expiry date of 10 years from the date of grant. The options were issued in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act.

 

In the first quarter of 2023, the Company entered into an Employment Agreement with Peter Hager, an officer of the Company. Under this Employment Agreement, the Company issued options to purchase 6,400,000 restricted shares of the Company’s common stock at a strike price of $0.06 per share and options to purchase 1,000,000 restricted shares of the Company’s common stock, at the commencement of his first renewal term of service. The options to purchase 6,400,000 restricted shares shall vest with respect to the first 400,000 shares on February 1, 2023, with the remaining 6,000,000 shares vesting in installments of 500,000 shares per fiscal quarter for each quarter of continuous service, beginning on April 1, 2023. The options were issued in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act.

 

In the first quarter of 2023, the Company entered into an Advisor Agreement with Greg Shockey, an advisor of the Company. Under this Advisor Agreement, the Company issued options to purchase 3,660,000 restricted shares of the Company’s common stock at a strike price of $0.06 per share. The options shall vest with respect to the first 60,000 shares on February 1, 2023, with the remaining 3,600,000 shares vesting in installments of 300,000 shares per fiscal quarter for each quarter of continuous service, beginning on April 1, 2023. The options were issued in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act.

 

 16 
 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINING SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

 

ITEM 6. EXHIBITS

 

  No. Description
     
  10.1 Advisor Agreement with Greg Shockey (previously filed on Form 8-K on February 7, 2023 as Exhibit 99.1, and incorporated herein by this reference.)
     
  10.2 Stock Option Grant and Stock Option Agreement with Greg Shockey (previously filed on Form 8-K on February 7, 2023 as Exhibit 99.2, and incorporated herein by this reference.)
     
  10.3 Employment Agreement with Peter Hager (previously filed on Form 8-K on February 7, 2023 as Exhibit 99.3, and incorporated herein by this reference.)
     
  10.4 Stock Option Grant and Stock Option Agreement with Peter Hager (previously filed on Form 8-K on February 7, 2023 as Exhibit 99.4, and incorporated herein by this reference.)
     
  10.5 Employment Agreement with Thomas Spruce (previously filed on Form 8-K on February 7, 2023 as Exhibit 99.5, and incorporated herein by this reference.)
     
  10.6 Stock Option Grant and Stock Option Agreement with Thomas Spruce (previously filed on Form 8-K on February 7, 2023 as Exhibit 99.6, and incorporated herein by this reference.)
     
  31.1 Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
  31.2 Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
  32.1 Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
  101.INS XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
     
  101.SCH XBRL Taxonomy Extension Schema Document
     
  101.CAL XBRL Taxonomy Calculation Linkbase Document
     
  101.DEF XBRL Taxonomy Extension Definition Linkbase Document
     
  101.LAB XBRL Taxonomy Label Linkbase Document
     
  101.PRE XBRL Taxonomy Presentation Linkbase Document

 

 17 
 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ELECTRONIC SERVITOR PUBLICATION NETWORK INC.
   
Dated: May 15, 2023

By:  /s/ Peter Hager

Peter Hager

Chief Executive Officer

   
 

By: /s/ Jim Kellogg

Jim Kellogg

Chief Financial Officer

 

 

 

18

 

 

 

 

 

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO

EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT 2002

 

I, Peter Hager, hereby certify that:

 

(1) I have reviewed this Quarterly Report on Form 10-Q for the period ending March 31, 2023 of Electronic Servitor Publication Network Inc.;

 

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

(4) The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

(5) The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated:  May 15, 2023

/s/ Peter Hager

Peter Hager

Chief Executive Officer

 

 

 

 

 

 

 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT 2002

 

I, Jim Kellogg, hereby certify that:

 

(1) I have reviewed this Quarterly Report on Form 10-Q for the period ending March 31, 2023 of Electronic Servitor Publication Network Inc.;

 

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

(4) The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

(5) The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Dated: May 15, 2023

/s/ Jim Kellogg

Jim Kellogg

Chief Financial Officer

 

 

 

 

 

 

 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of Electronic Servitor Publication Network Inc., a Delaware corporation (the "Company"), do hereby certify, to the best of their knowledge, that:

 

1.     The Quarterly Report on Form 10-Q for the period ending March 31, 2023 (the "Report") of the Company complies in all material respects with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  

 

 

 

Dated:  May 15, 2023

/s/ Peter Hager

Peter Hager

Chief Executive Officer

 

 

 

 

 

 
Dated: May 15, 2023

/s/ Jim Kellogg

Jim Kellogg

Chief Financial Officer

 

 

 

 

 

 

 

EX-101.SCH 5 xesp-20230331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - STATEMENTS OF CHANGES OF STOCKHOLDERS' DEFICIT (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - DESCRIPTION OF BUSINESS AND HISTORY link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - OPTIONS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - OPTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - DESCRIPTION OF BUSINESS AND HISTORY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - OPTIONS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - OPTIONS (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - WARRANTS (Details 1) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 xesp-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 xesp-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 8 xesp-20230331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Title of Individual [Axis] Chief Executive Officer [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Phitech Management L L C [Member] Third Party 1 [Member] Third Party 2 [Member] Third Party 3 [Member] Third Party 4 [Member] Third Party 5 [Member] Third Party 6 [Member] Legal Entity [Axis] Forty 7 Select Holdings L L C [Member] Award Type [Axis] Options [Member] Statistical Measurement [Axis] Minimum [Member] Class of Warrant or Right [Axis] Options Held [Member] Maximum [Member] Warrant [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] ASSETS Current assets: Cash Prepaid Total assets Current liabilities: Accounts payable and accruals Loans payable Due to a related party Total current liabilities Commitments and contingencies Stockholders’ Deficit: Preferred stock value Common Stock, $0.0001 par value, 100,000,000 shares authorized; 21,416,001 shares issued and outstanding Additional paid in capital Accumulated deficit Total Stockholders’ deficit Total Liabilities and Stockholders’ Deficit Preferred stock, par value Preferred stock shares, authorized Preferred stock, shares outstanding Preferred stock, shares issued Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Operating expenses: General and administrative Professional fees Stock based compensation Total operating expenses Loss from operations Other expense: Interest expense Total other expense Loss before provision for income taxes Provision for income taxes  Net loss Loss per share, basic and diluted Weighted average shares outstanding, basic and diluted Beginning balance, value Beginning balance, shares Warrant expense Stock option expense Net loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Changes in Operating Assets and Liabilities: Prepaid Accounts payable and accruals Net cash used by operating activities Cash flows from Investing activities: Cash flows from Financing activities: Proceeds from loans - related party Proceeds from loans payable Net cash provided by financing activities Net change in cash Cash, beginning of period Cash, end of period Cash Paid For: Cash paid for interest Cash paid for taxes Supplemental disclosure of non-cash activity: Conversion of debt Accounting Policies [Abstract] DESCRIPTION OF BUSINESS AND HISTORY SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] GOING CONCERN Notes Payable NOTES PAYABLE Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Equity [Abstract] PREFERRED STOCK Options OPTIONS Warrants WARRANTS Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Use of Estimates Concentrations of Credit Risk Cash equivalents Recently issued accounting pronouncements Options issued with the following inputs Schedule of options activity Schedule of stock options activity number of shares Schedule of common stock outstanding roll forward Schedule of weighted average number of shares Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Number of shares converted (in shares) Preferred stock, voting rights Number of shares cancelled Number of shares issued Stock issued during period, value, issued for services Share price Cash equivalents Accumulated deficit Notes payble Interest rate Interest accrued Maturity date Due from Related Parties Due to related party Note payable Maturity date Accrued interest Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock, shares authorized Preferred stock voting rights Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Options Exercise Price Warrant term Volatility Risk Free Interest Rate Dividend rate Number of options outstanding at beginning Weighted average exercise pricec at Beginning Number of options, Granted Weighted average exercise price, Granted Weighted average remaining contract term, Granted Number of options, Cancelled Weighted average remaining contract term at ending Number of options outstanding at ending Weighted average exercise pricec at ending Number of options exercisable (in shares) Weighted average exercise price exercisable Weighted average remaining contract term, exercisable Class of Warrant or Right, Outstanding Warrants and Rights Outstanding, Term Weighted average exercise price Number of warrants outstanding at beginning Weighted average exercise price at beginning Weighted average remaining contract term at beginning Number of warrants outstanding, Granted Number of warrants outstanding outstanding at ending Weighted average exercise price at ending Weighted average remaining contract term at ending Number of warrants exercisable (in shares) Weighted average exercise price exercisable Weighted average remaining contract term, exercisable Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Number outstanding Weighted average remaining contractual life (years) Assets Liabilities, Current Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Net Income (Loss) Attributable to Parent Shares, Outstanding Net Income (Loss) Available to Common Stockholders, Basic Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and Cash Equivalents, at Carrying Value Related Party Transaction, Date Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value WeightedAverageExercisePriceExercisable WeightedAverageRemainingContractTermExercisable EX-101.PRE 9 xesp-20230331_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
3 Months Ended
Mar. 31, 2023
May 09, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 000-55809  
Entity Registrant Name ELECTRONIC SERVITOR PUBLICATION NETWORK INC.  
Entity Central Index Key 0001709542  
Entity Tax Identification Number 82-1873116  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 400 1ST AVE N.  
Entity Address, Address Line Two STE. 100  
Entity Address, City or Town MINNEAPOLIS  
Entity Address, State or Province MN  
Entity Address, Postal Zip Code 55401  
City Area Code (833)  
Local Phone Number 991-0800  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   21,416,001
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.1
BALANCE SHEETS (UNAUDITED) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 8,812 $ 17,139
Prepaid 3,990
Total assets 12,802 17,139
Current liabilities:    
Accounts payable and accruals 51,517 49,680
Loans payable 79,630 52,630
Due to a related party 65,268 50,268
Total current liabilities 196,415 152,578
Commitments and contingencies
Stockholders’ Deficit:    
Preferred stock value
Common Stock, $0.0001 par value, 100,000,000 shares authorized; 21,416,001 shares issued and outstanding 2,142 2,142
Additional paid in capital 6,444,055 6,224,900
Accumulated deficit (6,629,810) (6,362,481)
Total Stockholders’ deficit (183,613) (135,439)
Total Liabilities and Stockholders’ Deficit 12,802 17,139
Series A Preferred Stock [Member]    
Stockholders’ Deficit:    
Preferred stock value
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.1
BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock shares, authorized 19,999,000 19,999,000
Preferred stock, shares outstanding 0 0
Preferred stock, shares issued 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 21,416,001 21,416,001
Common stock, shares outstanding 21,416,001 21,416,001
Series A Preferred Stock [Member]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock shares, authorized 1,000 1,000
Preferred stock, shares outstanding 1,000 1,000
Preferred stock, shares issued 1,000 1,000
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 30, 2022
Operating expenses:    
General and administrative $ 10,225 $ 1,659
Professional fees 35,021 25,000
Stock based compensation 219,155 97,435
Total operating expenses 264,401 124,094
Loss from operations (264,401) (124,094)
Other expense:    
Interest expense (2,928)
Total other expense (2,928)
Loss before provision for income taxes (267,329) (124,094)
Provision for income taxes
 Net loss $ (267,329) $ (124,094)
Loss per share, basic and diluted $ (0.01) $ (0.01)
Weighted average shares outstanding, basic and diluted 21,416,001 21,416,001
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF CHANGES OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 2,143 $ 5,876,611 $ (5,915,232) $ (36,478)
Beginning balance, shares at Dec. 31, 2021 1,000 21,416,001      
Warrant expense 97,435 97,435
Net loss (124,094) (124,094)
Ending balance, value at Mar. 31, 2022 $ 2,143 5,974,046 (6,039,326) (63,137)
Ending balance, shares at Mar. 31, 2022 1,000 21,416,001      
Beginning balance, value at Dec. 31, 2022 $ 2,142 6,224,900 (6,362,481) (135,439)
Beginning balance, shares at Dec. 31, 2022 1,000 21,416,001      
Stock option expense 219,155 219,155
Net loss (267,329) (267,329)
Ending balance, value at Mar. 31, 2023 $ 2,142 $ 6,444,055 $ (6,629,810) $ (183,613)
Ending balance, shares at Mar. 31, 2023 1,000 21,416,001      
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 30, 2022
Cash flows from operating activities:    
Net loss $ (267,329) $ (124,094)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 219,155 97,435
Changes in Operating Assets and Liabilities:    
Prepaid (3,990)
Accounts payable and accruals 1,837 11,617
Net cash used by operating activities (50,327) (15,042)
Cash flows from Investing activities:
Cash flows from Financing activities:    
Proceeds from loans - related party 15,000 19,643
Proceeds from loans payable 27,000
Net cash provided by financing activities 42,000 19,643
Net change in cash (8,327) 4,601
Cash, beginning of period 17,139
Cash, end of period 8,812 4,601
Cash Paid For:    
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash activity:    
Conversion of debt $ 14,500
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
DESCRIPTION OF BUSINESS AND HISTORY
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
DESCRIPTION OF BUSINESS AND HISTORY

 NOTE 1 - DESCRIPTION OF BUSINESS AND HISTORY

 

Description of business

 

The Company was originally incorporated on May 17, 2017, under the laws of the State of Delaware to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions. On May 23, 2018, the Certificate of Incorporation of the Company was amended to effect a change in the Company’s name from “Iris Grove Acquisition Corporation” to “CannAssist International Corporation”. On September 28, 2021, the Certificate of Incorporation of the Company was amended a second time to effect a change in the Company’s name from “CannAssist International Corporation” to the name “Electronic Servitor Publication Network, Inc.” The Company’s common stock trades on the OTCQB Venture Market under the stock ticker symbol “XESP,” previously from “CNSC,” effective January 26, 2022. The Company's corporate office is located at 400 1ST Ave N., Ste. 100, Minneapolis, MN 55401. The URL of the Company’s website is https://www.xespn.com. The Company’s telephone number is (833) 991-0800.

 

The Company’s business focuses on driving growth for Brands through effective digital interactions within current and new communities. The Company’s proprietary technology, the Digital Engagement Engine, utilizes a combination of automation, unique data management, and a modern workflow built on a microservices architecture to achieve greater reach and lift for content providers.

 

On July 1, 2021, and effective on October 9, 2021, Mark Palumbo, a former officer and director of the Company, and Forty 7 Select Holdings LLC, an entity controlled by Greg Shockey (who was an existing shareholder of the Company), entered into an agreement pursuant to which Mark Palumbo transferred all of his 1,000 shares of Series A Preferred Stock (representing 100% of the Company’s issued and outstanding Series A Preferred Stock), of the Company to Forty 7 Select Holdings LLC in a private transaction. The Series A Preferred Stock provides the holder thereof the right to vote 60% of the Company’s voting shares on any and all shareholder matters and thereby constituted a change of control of the Company. Further, Mark Palumbo contributed 7,500,000 shares of common stock held by him to the treasury of the Company for cancellation at no cost (the “Contribution”).

 

On July 23, 2021, the Company entered into a Technology License Agreement with Phitech Management, LLC, an entity controlled by Peter Hager (“Licensor”), to use, market, promote and distribute certain technology relating to content provisioning including the related patent applications, trade-secrets and associated knowhow, including methods, techniques, specifications, procedures, information, systems, knowledge and business processes required to practice and carry on business in the field of data collection, security and management (the “Technology”). The initial term of the License is 10-years (the “Initial Term”) and shall automatically be renewed for successive 1-year terms (each, a “Renewal Term”) unless the Company elects to terminate the License by giving 30 days’ written notice prior to commencement of a Renewal Term. In exchange for the License of the Technology, the Company issues to the Licensor 10,000,000 restricted shares of its common stock (which is an amount equal to $2,500,000 divided by $0.25, which was the closing market price of the Company’s common stock on the trading day prior to the effective date of the License Agreement). On October 9, 2021, at the Closing of the Technology License Agreement, the Company received the License to the Technology and issued Licensor 10,000,000 restricted shares of the Company’s common stock, at a cost basis of $0.25 per share.

 

On July 23, 2021, the Company and Mark Palumbo entered into an agreement (the “Spin-Off Agreement”) whereby, at the Closing, the Company shall transfer 100% of the issued and outstanding membership units of Xceptor LLC, an entity that was a wholly-owned subsidiary of the Company, to Mark Palumbo (along with the assets and liabilities associated with the prior business) for nominal consideration as a condition of the Change-in-Control (the “Spin-Off”). Furthermore, at the Closing, that certain Technology License Agreement entered into by and between the Company and Mark Palumbo dated April 29, 2019 (the “Palumbo License Agreement”) shall be terminated and the Company shall assign all rights to the underlying Intellectual Property (as defined in the Palumbo License Agreement) to Mark Palumbo. On October 9, 2021, at the Closing of the Spin-Off Agreement, the Company transferred 100% of the issued and outstanding membership units of Xceptor LLC to Mark Palumbo (along with the assets and liabilities associated with the prior business) in exchange for nominal consideration, and the Palumbo License Agreement was terminated.

 

As a result of the transactions described above, the Company is strategically aligning its business to support its mission in becoming the premier content management and distribution platform for content providers in the global markets through the Company’s continued development and acquisitions of publication and monetization products, services, and technologies.

 

Effective October 9, 2021, as a result of the transactions described above, the business of the Company changed to focus on Electronic Sports Gaming technology and the development of related infrastructure, specifically the development and commercialization of a technology platform specifically designed for the Electronic Sports and Electronic Gaming markets. The platform will provide an omni-channel publishing tool, with talent identity protection and monetization tools provided in line with interaction and media creation services. Further publication and monetization products and services will be developed and acquired to support these efforts.

 

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Company’s unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the three month period ending March 31, 2023 and not necessarily indicative of the results to be expected for the full year ending December 31, 2023. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentrations of Credit Risk

 

We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).

 

Cash equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents for the periods ended March 31, 2023 and December 31, 2022.

 

Recently issued accounting pronouncements

 

The Company has implemented all new applicable accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.1
GOING CONCERN
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 3 - GOING CONCERN

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has no current source of revenue and an accumulated deficit of $6,629,810 as of March 31, 2023. The Company’s continuation as a going concern is dependent upon its ability to generate revenue to satisfy its obligations on a timely basis and ultimately to attain profitability. There is no guarantee that the Company’s activities will generate sufficient revenues to sustain its operations, or its ability to sell its services to generate consistent profitability. In order to maintain operations, the Company may have to raise additional capital from equity financing and/or from its officers, directors, or principal stockholders, subject to terms obtainable and satisfactory to the Company. There is no guarantee that the Company will be able to raise additional funds or to do so at an advantageous price. The financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE
3 Months Ended
Mar. 31, 2023
Notes Payable  
NOTES PAYABLE

NOTE 4 - NOTES PAYABLE

 

On May 19, 2022, the Company issued a note payable for $10,000 to a third party. The note matures in one year and bears interest at 6% per annum. As of March 31, 2023, there is $519 of interest accrued on this note.

 

On May 20, 2022, the Company issued a note payable for $10,000 to a third party. The note matures in one year and bears interest at 6% per annum. As of March 31, 2023, there is $518 of interest accrued on this note.

 

On June 10, 2022, the Company issued a note payable for $7,630 to a third party. The note matures in 6 months and bears interest at 10% per annum. As of March 31, 2023, there is $615 of interest accrued on this note.

 

On October 18, 2022, the Company issued a note payable for $25,000 to a third party. The note matures in one year and bears interest at 8% per annum. As of March 31, 2023, there is $899 of interest accrued on this note.

 

On January 6, 2023, the Company issued a note payable for $15,000 to a third party. The note matures on July 6, 2023, and bears interest at 8.5% per annum. As of March 31, 2023, there is $293 of interest accrued on this note.

 

On March 13, 2023, the Company issued a note payable for $12,000 to a third party. The note matures on September 13, 2023, and bears interest at 8.5% per annum. As of March 31, 2023, there is $50 of interest accrued on this note.

 

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

 

During the year ended December 31, 2022, Forty 7 Select Holdings LLC (“Forty 7”) advanced the Company $27,643, to pay for general operating expenses. Forty 7 is controlled by Greg Shockey, an existing shareholder of the Company. As of March 31, 2023, the balance due to Forty 7 is $50,268.

 

On January 10, 2023, the Company issued a note payable for $15,000 to Forty 7. The note matures on July 10, 2023, and bears interest at 8.5% per annum. As of March 31, 2023, there is $279 of interest accrued on this note.

 

Refer to Note 7 for options to purchase shares of common stock issued to related parties.

 

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.1
PREFERRED STOCK
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
PREFERRED STOCK

NOTE 6 – PREFERRED STOCK

 

The Company has designated 1,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock have a par value of $0.0001 per share. The Series A Preferred Shares do not have a dividend rate or liquidation preference and are not convertible into shares of common stock. Series A Preferred Stock, voting together as a class, have the right to vote 60% of the Company’s voting shares on any and all shareholder matters (the “Majority Voting Rights”). Additionally, the Company shall not adopt any amendments to the Company’s Bylaws, Articles of Incorporation, as amended, make any changes to the Certificate of Designations establishing the Series A Preferred Stock, or effect any reclassification of the Series A Preferred Stock, without the affirmative vote of at least a majority of the outstanding shares of Series A Preferred Stock. However, the Company may, by any means authorized by law and without any vote of the holders of shares of Series A Preferred Stock, make technical, corrective, administrative or similar changes to such Certificate of Designations that do not, individually or in the aggregate, adversely affect the rights or preferences of the holders of shares of Series A Preferred Stock. Other than the Majority Voting Rights, the Series A Preferred Stock does not have any other dividend, liquidation, conversion, or redemption rights, whatsoever.

 

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.1
OPTIONS
3 Months Ended
Mar. 31, 2023
Options  
OPTIONS

NOTE 7 – OPTIONS

 

In the first quarter of 2022, the Company entered into an Employment Agreement with Thomas Spruce, an officer and director of the Company. This Employment Agreement has a term of 2 years and automatically renews for an additional 6-month term unless terminated earlier. This agreement is terminable by each of the parties upon written notice. Under this Employment Agreement, the Company pays a base salary of $1.00 per year and issued options to purchase 500,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of two years and expire 10 years from the date of grant.

 

Effective April 12, 2022, the Company entered into an Advisory Agreement with Greg Shockey, an affiliate of the Company and service provider. Under this Advisory Agreement, the Company issued options to purchase 240,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant.

 

Effective April 12, 2022, the Company entered into an Advisory Agreement with Danijella Dragas, a third-party service provider. Under this Advisory Agreement, the Company issued options to purchase 240,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant. On March 23, 2023, the Advisory Agreement was cancelled, thereby terminating Danijella Dragas and forfeiting 60,000 unvested options.

 

On May 27, 2022, the Company entered into an Addendum to Employment Agreement with Thomas Spruce, which granted Mr. Spruce options to purchase an additional 250,000 restricted shares of the Company’s common stock at a strike price of $0.15 per share. The options vest immediately from the date of the grant and expire 10 years from the date of grant.

 

On November 16, 2022, the Company entered into an Employment Agreement with Jim Kellogg, which granted Mr. Kellogg options to purchase 300,000 restricted shares of the Company’s common stock at a strike price of $0.10 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant.

 

On February 1, 2023, the Company entered into an Advisor Agreement with Greg Shockey, which supersedes his previous Advisor Agreement with the Company, whereby, in exchange for business development and strategy consulting, investor relations, and facilitating meetings with targeted investors, as well as other services, the Company agreed to issue Greg Shockey options to purchase 60,000 restricted shares of common stock at signing and an additional 1,200,000 shares of restricted common stock every year thereafter for three years.

 

On February 1, 2023, Peter Hager was appointed as the Company’s President and Chief Executive Officer. Per the terms of the employment agreement Mr. Hager was granted options to purchase 6,400,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $0.06 per share, vesting in installments of 500,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and 1,000,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service.

 

On February 1, 2033, Thomas Spruce was appointed as the Company’s Secretary and Chief Operations Officer. Per the terms of the employment agreement Mr. Spruce was granted options to purchase 1,750,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $0.06 per share, vesting with respect to the first 250,000 shares on February 1, 2023 and vesting with respect to the remaining 1,500,000 shares in installments of 125,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and 250,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service.

     

Options issued in the three months ended March 31, 2023, with the following inputs:

Options   11,810,000 
Share price  $0.066 
Exercise Price  $0.06 
Term   10 years 
Volatility   209.39%
Risk Free Interest Rate   3.39%
Dividend rate    

 

A summary of the status of the Company’s outstanding stock options and changes during the year is presented below:

                    
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
Term
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021      $       $ 
Granted   2,030,000   $0.36    10   $ 
Cancelled   (250,000)  $       $ 
Exercised      $       $ 
Outstanding at December 31, 2022   1,780,000   $0.35    9.81   $ 
Granted   11,810,000   $0.06    10   $ 
Cancelled   (60,000)  $       $ 
Exercised      $       $ 
Outstanding at March 31, 2023   13,530,000   $0.09    9.75   $ 
Exercisable at March 31, 2023   2,220,000   $0.24    9.34   $ 

 

           
Range of Exercise
Prices
  Number Outstanding
3/31/2023
  Weighted Average
Remaining
Contractual Life
  Weighted Average
Exercise Price
$0.060.39   13,590,000   9.75 years   $0.09

 

 

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.1
WARRANTS
3 Months Ended
Mar. 31, 2023
Warrants  
WARRANTS

NOTE 8 – WARRANTS

 

A summary of the status of the Company’s outstanding stock warrants and changes during the year is presented below:

Schedule of common stock outstanding roll forward                    
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
Term
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021   153,503   $0.25    6.92   $ 
Granted      $       $ 
Expired      $       $ 
Exercised      $       $ 
Outstanding at December 31, 2022   153,503   $0.25    5.92   $ 
Granted      $       $ 
Expired      $       $ 
Exercised      $       $ 
Exercisable at March 31, 2023   153,503   $0.25    5.67   $ 

 

           
Range of Exercise
Prices
  Number Outstanding
3/31/2023
  Weighted Average
Remaining
Contractual Life
  Weighted Average
Exercise Price
$0.25   153,503   5.67 years   $0.25

 

 

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were issued and has determined that there are no material subsequent events to disclose in these financial statements.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The Company’s unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the three month period ending March 31, 2023 and not necessarily indicative of the results to be expected for the full year ending December 31, 2023. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentrations of Credit Risk

Concentrations of Credit Risk

 

We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).

 

Cash equivalents

Cash equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents for the periods ended March 31, 2023 and December 31, 2022.

 

Recently issued accounting pronouncements

Recently issued accounting pronouncements

 

The Company has implemented all new applicable accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.1
OPTIONS (Tables)
3 Months Ended
Mar. 31, 2023
Options  
Options issued with the following inputs
     

Options issued in the three months ended March 31, 2023, with the following inputs:

Options   11,810,000 
Share price  $0.066 
Exercise Price  $0.06 
Term   10 years 
Volatility   209.39%
Risk Free Interest Rate   3.39%
Dividend rate    
Schedule of options activity
                    
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
Term
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021      $       $ 
Granted   2,030,000   $0.36    10   $ 
Cancelled   (250,000)  $       $ 
Exercised      $       $ 
Outstanding at December 31, 2022   1,780,000   $0.35    9.81   $ 
Granted   11,810,000   $0.06    10   $ 
Cancelled   (60,000)  $       $ 
Exercised      $       $ 
Outstanding at March 31, 2023   13,530,000   $0.09    9.75   $ 
Exercisable at March 31, 2023   2,220,000   $0.24    9.34   $ 
Schedule of stock options activity number of shares
           
Range of Exercise
Prices
  Number Outstanding
3/31/2023
  Weighted Average
Remaining
Contractual Life
  Weighted Average
Exercise Price
$0.060.39   13,590,000   9.75 years   $0.09
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.1
WARRANTS (Tables)
3 Months Ended
Mar. 31, 2023
Warrants  
Schedule of common stock outstanding roll forward
Schedule of common stock outstanding roll forward                    
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contract
Term
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021   153,503   $0.25    6.92   $ 
Granted      $       $ 
Expired      $       $ 
Exercised      $       $ 
Outstanding at December 31, 2022   153,503   $0.25    5.92   $ 
Granted      $       $ 
Expired      $       $ 
Exercised      $       $ 
Exercisable at March 31, 2023   153,503   $0.25    5.67   $ 
Schedule of weighted average number of shares
           
Range of Exercise
Prices
  Number Outstanding
3/31/2023
  Weighted Average
Remaining
Contractual Life
  Weighted Average
Exercise Price
$0.25   153,503   5.67 years   $0.25
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
DESCRIPTION OF BUSINESS AND HISTORY (Details Narrative) - USD ($)
Oct. 09, 2021
Jul. 23, 2021
Jul. 01, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of shares issued 10,000,000    
Share price $ 0.25    
Phitech Management L L C [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of shares issued   10,000,000  
Stock issued during period, value, issued for services   $ 2,500,000  
Share price   $ 0.25  
Chief Executive Officer [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]      
Number of shares converted (in shares)     1,000
Preferred stock, voting rights     Preferred Stock provides the holder thereof the right to vote 60% of the Company’s voting shares on any and all shareholder matters and thereby constituted a change of control of the Company
Number of shares cancelled     7,500,000
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Cash equivalents $ 0 $ 0
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
GOING CONCERN (Details Narrative) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 6,629,810 $ 6,362,481
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended
Mar. 13, 2023
Jan. 06, 2023
Jun. 10, 2022
Oct. 18, 2022
May 20, 2022
May 19, 2022
Mar. 31, 2023
Third Party 1 [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Notes payble           $ 10,000  
Interest rate           6.00%  
Interest accrued             $ 519
Third Party 2 [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Notes payble         $ 10,000    
Interest rate         6.00%    
Interest accrued             518
Third Party 3 [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Notes payble     $ 7,630        
Interest rate     10.00%        
Interest accrued             615
Third Party 4 [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Notes payble       $ 25,000      
Interest rate       8.00%      
Interest accrued             899
Third Party 5 [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Notes payble   $ 15,000          
Interest rate   8.50%          
Interest accrued             293
Maturity date   Jul. 06, 2023          
Third Party 6 [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Notes payble $ 12,000            
Interest rate 8.50%            
Interest accrued             $ 50
Maturity date Sep. 13, 2023            
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
Jan. 10, 2023
Mar. 31, 2023
Dec. 31, 2022
Due to related party   $ 65,268 $ 50,268
Forty 7 Select Holdings L L C [Member]      
Due from Related Parties     $ 27,643
Due to related party   50,268  
Note payable $ 15,000    
Maturity date Jul. 10, 2023    
Interest rate 8.50%    
Accrued interest   $ 279  
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.1
PREFERRED STOCK (Details Narrative) - $ / shares
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Class of Stock [Line Items]    
Preferred stock, shares authorized 19,999,000 19,999,000
Preferred stock, par value $ 0.0001 $ 0.0001
Series A Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred stock, shares authorized 1,000 1,000
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock voting rights Series A Preferred Stock, voting together as a class, have the right to vote 60% of the Company’s voting shares  
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.1
OPTIONS (Details) - $ / shares
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Oct. 09, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share price       $ 0.25
Warrant term   5 years 11 months 1 day 6 years 11 months 1 day  
Options [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Options 11,810,000      
Share price $ 0.066      
Exercise Price $ 0.06      
Warrant term 10 years      
Volatility 209.39%      
Risk Free Interest Rate 3.39%      
Dividend rate      
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.1
OPTIONS (Details 1) - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Options    
Number of options outstanding at beginning 1,780,000
Weighted average exercise pricec at Beginning $ 0.35
Number of options, Granted 11,810,000 2,030,000
Weighted average exercise price, Granted $ 0.06 $ 0.36
Weighted average remaining contract term, Granted 10 years 10 years
Number of options, Cancelled (60,000) (250,000)
Weighted average remaining contract term at ending 9 years 9 months 9 years 9 months 21 days
Number of options outstanding at ending 13,530,000 1,780,000
Weighted average exercise pricec at ending $ 0.09 $ 0.35
Number of options exercisable (in shares) 2,220,000  
Weighted average exercise price exercisable $ 0.24  
Weighted average remaining contract term, exercisable 9 years 4 months 2 days  
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
OPTIONS (Details 2) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Warrants and Rights Outstanding, Term   5 years 11 months 1 day 6 years 11 months 1 day
Options Held [Member]      
Class of Warrant or Right, Outstanding 13,590,000    
Warrants and Rights Outstanding, Term 9 years 9 months    
Weighted average exercise price $ 0.09    
Minimum [Member] | Options Held [Member]      
Exercise Price 0.06    
Maximum [Member] | Options Held [Member]      
Exercise Price $ 0.39    
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.1
WARRANTS (Details) - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Warrants    
Number of warrants outstanding at beginning 153,503 153,503
Weighted average exercise price at beginning $ 0.25 $ 0.25
Weighted average remaining contract term at beginning 5 years 11 months 1 day 6 years 11 months 1 day
Number of warrants outstanding, Granted  
Number of warrants outstanding outstanding at ending   153,503
Weighted average exercise price at ending   $ 0.25
Weighted average remaining contract term at ending   5 years 11 months 1 day
Number of warrants exercisable (in shares) 153,503  
Weighted average exercise price exercisable $ 0.25  
Weighted average remaining contract term, exercisable 5 years 8 months 1 day  
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
WARRANTS (Details 1) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Class of Warrant or Right [Line Items]      
Weighted average remaining contractual life (years)   5 years 11 months 1 day 6 years 11 months 1 day
Warrant [Member]      
Class of Warrant or Right [Line Items]      
Exercise Price $ 0.25    
Number outstanding 153,503    
Weighted average remaining contractual life (years) 5 years 8 months 1 day    
Weighted average exercise price $ 0.25    
XML 39 j5923110q_htm.xml IDEA: XBRL DOCUMENT 0001709542 2023-01-01 2023-03-31 0001709542 2023-05-09 0001709542 2023-03-31 0001709542 2022-12-31 0001709542 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001709542 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001709542 2022-01-01 2022-03-30 0001709542 us-gaap:PreferredStockMember 2022-12-31 0001709542 us-gaap:CommonStockMember 2022-12-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001709542 us-gaap:RetainedEarningsMember 2022-12-31 0001709542 us-gaap:PreferredStockMember 2021-12-31 0001709542 us-gaap:CommonStockMember 2021-12-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001709542 us-gaap:RetainedEarningsMember 2021-12-31 0001709542 2021-12-31 0001709542 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001709542 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001709542 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001709542 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001709542 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001709542 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001709542 2022-01-01 2022-03-31 0001709542 us-gaap:PreferredStockMember 2023-03-31 0001709542 us-gaap:CommonStockMember 2023-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001709542 us-gaap:RetainedEarningsMember 2023-03-31 0001709542 us-gaap:PreferredStockMember 2022-03-31 0001709542 us-gaap:CommonStockMember 2022-03-31 0001709542 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001709542 us-gaap:RetainedEarningsMember 2022-03-31 0001709542 2022-03-31 0001709542 2022-03-30 0001709542 srt:ChiefExecutiveOfficerMember 2021-06-28 2021-07-01 0001709542 xesp:PhitechManagementLLCMember 2021-07-20 2021-07-23 0001709542 xesp:PhitechManagementLLCMember 2021-07-23 0001709542 2021-10-07 2021-10-09 0001709542 2021-10-09 0001709542 xesp:ThirdParty1Member 2022-05-19 0001709542 xesp:ThirdParty1Member 2022-05-01 2022-05-19 0001709542 xesp:ThirdParty1Member 2023-03-31 0001709542 xesp:ThirdParty2Member 2022-05-20 0001709542 xesp:ThirdParty2Member 2022-05-01 2022-05-20 0001709542 xesp:ThirdParty2Member 2023-03-31 0001709542 xesp:ThirdParty3Member 2022-06-10 0001709542 xesp:ThirdParty3Member 2022-06-01 2022-06-10 0001709542 xesp:ThirdParty3Member 2023-03-31 0001709542 xesp:ThirdParty4Member 2022-10-18 0001709542 xesp:ThirdParty4Member 2022-10-01 2022-10-18 0001709542 xesp:ThirdParty4Member 2023-03-31 0001709542 xesp:ThirdParty5Member 2023-01-06 0001709542 xesp:ThirdParty5Member 2023-01-01 2023-01-06 0001709542 xesp:ThirdParty5Member 2023-03-31 0001709542 xesp:ThirdParty6Member 2023-03-13 0001709542 xesp:ThirdParty6Member 2023-03-01 2023-03-13 0001709542 xesp:ThirdParty6Member 2023-03-31 0001709542 xesp:Forty7SelectHoldingsLLCMember 2022-12-31 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-03-31 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-01-10 0001709542 xesp:Forty7SelectHoldingsLLCMember 2023-01-01 2023-01-10 0001709542 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001709542 xesp:OptionsMember 2023-03-31 0001709542 xesp:OptionsMember 2023-01-01 2023-03-31 0001709542 2022-01-01 2022-12-31 0001709542 srt:MinimumMember us-gaap:OptionMember 2023-03-31 0001709542 srt:MaximumMember us-gaap:OptionMember 2023-03-31 0001709542 us-gaap:OptionMember 2023-03-31 0001709542 us-gaap:WarrantMember 2023-03-31 iso4217:USD shares iso4217:USD shares pure 0001709542 false 2023 Q1 --12-31 10-Q true 2023-03-31 false 000-55809 ELECTRONIC SERVITOR PUBLICATION NETWORK INC. DE 82-1873116 400 1ST AVE N. STE. 100 MINNEAPOLIS MN 55401 (833) 991-0800 Yes Yes Non-accelerated Filer true false false 21416001 8812 17139 3990 12802 17139 51517 49680 79630 52630 65268 50268 196415 152578 0.0001 0.0001 19999000 19999000 0 0 0 0 0.0001 0.0001 1000 1000 1000 1000 1000 1000 0.0001 0.0001 100000000 100000000 21416001 21416001 21416001 21416001 2142 2142 6444055 6224900 -6629810 -6362481 -183613 -135439 12802 17139 10225 1659 35021 25000 219155 97435 264401 124094 -264401 -124094 2928 -2928 -267329 -124094 -267329 -124094 -0.01 -0.01 21416001 21416001 1000 21416001 2142 6224900 -6362481 -135439 219155 219155 -267329 -267329 1000 21416001 2142 6444055 -6629810 -183613 1000 21416001 2143 5876611 -5915232 -36478 97435 97435 -124094 -124094 1000 21416001 2143 5974046 -6039326 -63137 -267329 -124094 219155 97435 3990 1837 11617 -50327 -15042 15000 19643 27000 42000 19643 -8327 4601 17139 8812 4601 14500 <p id="xdx_80B_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zOhZaecnAoxi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <b>NOTE 1 - <span id="xdx_828_zx4AO3YO86Dg">DESCRIPTION OF BUSINESS AND HISTORY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Description of business</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was originally incorporated on May 17, 2017, under the laws of the State of Delaware to engage in any lawful corporate undertaking, including, but not limited to, selected mergers and acquisitions. On May 23, 2018, the Certificate of Incorporation of the Company was amended to effect a change in the Company’s name from “Iris Grove Acquisition Corporation” to “CannAssist International Corporation”. On September 28, 2021, the Certificate of Incorporation of the Company was amended a second time to effect a change in the Company’s name from “CannAssist International Corporation” to the name “Electronic Servitor Publication Network, Inc.” The Company’s common stock trades on the OTCQB Venture Market under the stock ticker symbol “XESP,” previously from “CNSC,” effective January 26, 2022. The Company's corporate office is located at 400 1ST Ave N., Ste. 100, Minneapolis, MN 55401. The URL of the Company’s website is https://www.xespn.com. The Company’s telephone number is (833) 991-0800.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s business focuses on driving growth for Brands through effective digital interactions within current <span style="background-color: white">and new communities. The Company’s proprietary technology, the Digital Engagement Engine, utilizes a combination of automation, unique data management, and a modern workflow built on a microservices architecture to achieve greater reach and lift for content providers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 1, 2021, and effective on October 9, 2021, Mark Palumbo, a former officer and director of the Company, and Forty 7 Select Holdings LLC, an entity controlled by Greg Shockey (who was an existing shareholder of the Company), entered into an agreement pursuant to which Mark Palumbo transferred all of his <span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20210628__20210701__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zzmMbfSTfsa6" title="Number of shares converted (in shares)">1,000</span> shares of Series A Preferred Stock (representing 100% of the Company’s issued and outstanding Series A Preferred Stock), of the Company to Forty 7 Select Holdings LLC in a private transaction. The Series A <span id="xdx_903_eus-gaap--PreferredStockVotingRights_c20210628__20210701__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zpI9QJIRNb52" title="Preferred stock, voting rights">Preferred Stock provides the holder thereof the right to vote 60% of the Company’s voting shares on any and all shareholder matters and thereby constituted a change of control of the Company</span>. Further, Mark Palumbo contributed <span id="xdx_90A_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20210628__20210701__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zFVycpKa0Sg5" title="Number of shares cancelled">7,500,000</span> shares of common stock held by him to the treasury of the Company for cancellation at no cost (the “Contribution”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 23, 2021, the Company entered into a Technology License Agreement with Phitech Management, LLC, an entity controlled by Peter Hager (“Licensor”), to use, market, promote and distribute certain technology relating to content provisioning including the related patent applications, trade-secrets and associated knowhow, including methods, techniques, specifications, procedures, information, systems, knowledge and business processes required to practice and carry on business in the field of data collection, security and management (the “Technology”). The initial term of the License is 10-years (the “Initial Term”) and shall automatically be renewed for successive 1-year terms (each, a “Renewal Term”) unless the Company elects to terminate the License by giving 30 days’ written notice prior to commencement of a Renewal Term. In exchange for the License of the Technology, the Company issues to the Licensor <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210720__20210723__us-gaap--TypeOfArrangementAxis__custom--PhitechManagementLLCMember_pdd" title="Number of shares issued">10,000,000</span> restricted shares of its common stock (which is an amount equal to $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210720__20210723__us-gaap--TypeOfArrangementAxis__custom--PhitechManagementLLCMember_pp0p0" title="Stock issued during period, value, issued for services">2,500,000</span> divided by $<span id="xdx_90E_eus-gaap--SharePrice_c20210723__us-gaap--TypeOfArrangementAxis__custom--PhitechManagementLLCMember_pdd" title="Share price">0.25</span>, which was the closing market price of the Company’s common stock on the trading day prior to the effective date of the License Agreement). On October 9, 2021, at the Closing of the Technology License Agreement, the Company received the License to the Technology and issued Licensor <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20211007__20211009_pdd" title="Number of shares issued">10,000,000</span> restricted shares of the Company’s common stock, at a cost basis of $<span id="xdx_909_eus-gaap--SharePrice_c20211009_pdd" title="Share price">0.25</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 23, 2021, the Company and Mark Palumbo entered into an agreement (the “Spin-Off Agreement”) whereby, at the Closing, the Company shall transfer 100% of the issued and outstanding membership units of Xceptor LLC, an entity that was a wholly-owned subsidiary of the Company, to Mark Palumbo (along with the assets and liabilities associated with the prior business) for nominal consideration as a condition of the Change-in-Control (the “Spin-Off”). Furthermore, at the Closing, that certain Technology License Agreement entered into by and between the Company and Mark Palumbo dated April 29, 2019 (the “Palumbo License Agreement”) shall be terminated and the Company shall assign all rights to the underlying Intellectual Property (as defined in the Palumbo License Agreement) to Mark Palumbo. On October 9, 2021, at the Closing of the Spin-Off Agreement, the Company transferred 100% of the issued and outstanding membership units of Xceptor LLC to Mark Palumbo (along with the assets and liabilities associated with the prior business) in exchange for nominal consideration, and the Palumbo License Agreement was terminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the transactions described above, the Company is strategically aligning its business to support its mission in becoming the premier content management and distribution platform for content providers in the global markets through the Company’s continued development and acquisitions of publication and monetization products, services, and technologies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective October 9, 2021, as a result of the transactions described above, the business of the Company changed to focus on Electronic Sports Gaming technology and the development of related infrastructure, specifically the development and commercialization of a technology platform specifically designed for the Electronic Sports and Electronic Gaming markets. The platform will provide an omni-channel publishing tool, with talent identity protection and monetization tools provided in line with interaction and media creation services. Further publication and monetization products and services will be developed and acquired to support these efforts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1000 Preferred Stock provides the holder thereof the right to vote 60% of the Company’s voting shares on any and all shareholder matters and thereby constituted a change of control of the Company 7500000 10000000 2500000 0.25 10000000 0.25 <p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_znvExNDjH1Ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 - <span id="xdx_824_z6KYP7mc1mgh">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b/></p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVvw8FTNLH78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86A_zACxpgk4xEA4">Basis of Presentation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the three month period ending March 31, 2023 and not necessarily indicative of the results to be expected for the full year ending December 31, 2023. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--UseOfEstimates_zkWZYOhw7Tdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zE6ssD38akSb">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zLOePiWE91x9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zJeam2BuabHd">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zYTMhRPHES94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Cash equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were <span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20230331_zsUepp8Rn5ra" title="Cash equivalents"><span id="xdx_907_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20221231_zdgNGeiUH024" title="Cash equivalents">no</span></span> cash equivalents for the periods ended March 31, 2023 and December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlWpFXrtxUqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_867_z1RRibuthGK8">Recently issued accounting pronouncements</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has implemented all new applicable accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVvw8FTNLH78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86A_zACxpgk4xEA4">Basis of Presentation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company as of and for the three month period ending March 31, 2023 and not necessarily indicative of the results to be expected for the full year ending December 31, 2023. These unaudited financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--UseOfEstimates_zkWZYOhw7Tdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zE6ssD38akSb">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zLOePiWE91x9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86E_zJeam2BuabHd">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zYTMhRPHES94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Cash equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were <span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20230331_zsUepp8Rn5ra" title="Cash equivalents"><span id="xdx_907_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_do_c20221231_zdgNGeiUH024" title="Cash equivalents">no</span></span> cash equivalents for the periods ended March 31, 2023 and December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0 0 <p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlWpFXrtxUqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_867_z1RRibuthGK8">Recently issued accounting pronouncements</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"> </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has implemented all new applicable accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_80D_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zb4k0xMZMFz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 - <span id="xdx_82C_zBYn2wdkmAfd">GOING CONCERN</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has no current source of revenue and an accumulated deficit of $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20230331_zG30XKhNN8Yi" title="Accumulated deficit">6,629,810</span> as of March 31, 2023. The Company’s continuation as a going concern is dependent upon its ability to generate revenue to satisfy its obligations on a timely basis and ultimately to attain profitability. There is no guarantee that the Company’s activities will generate sufficient revenues to sustain its operations, or its ability to sell its services to generate consistent profitability. In order to maintain operations, the Company may have to raise additional capital from equity financing and/or from its officers, directors, or principal stockholders, subject to terms obtainable and satisfactory to the Company. There is no guarantee that the Company will be able to raise additional funds or to do so at an advantageous price. The financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> -6629810 <p id="xdx_807_ecustom--NotesPayableTextBlock_zqxmFNxbGltk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 - <span id="xdx_825_zizARfMjqpKh">NOTES PAYABLE</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 19, 2022, the Company issued a note payable for $<span id="xdx_90E_eus-gaap--NotesPayableCurrent_c20220519__srt--TitleOfIndividualAxis__custom--ThirdParty1Member_pp0p0" title="Notes payble">10,000</span> to a third party. The note matures in one year and bears interest at <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220501__20220519__srt--TitleOfIndividualAxis__custom--ThirdParty1Member_zFICUc88GzF1" title="Interest rate">6</span>% per annum. As of March 31, 2023, there is $<span id="xdx_90F_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20230331__srt--TitleOfIndividualAxis__custom--ThirdParty1Member_zdycpGqQMXzj" title="Interest accrued">519</span> of interest accrued on this note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 20, 2022, the Company issued a note payable for $<span id="xdx_90E_eus-gaap--NotesPayableCurrent_c20220520__srt--TitleOfIndividualAxis__custom--ThirdParty2Member_pp0p0" title="Notes payble">10,000</span> to a third party. The note matures in one year and bears interest at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220501__20220520__srt--TitleOfIndividualAxis__custom--ThirdParty2Member_zajLqmmdlHN3" title="Interest rate">6</span>% per annum. As of March 31, 2023, there is $<span id="xdx_907_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20230331__srt--TitleOfIndividualAxis__custom--ThirdParty2Member_zQDDPdfZS1j3" title="Interest accrued">518</span> of interest accrued on this note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 10, 2022, the Company issued a note payable for $<span id="xdx_90F_eus-gaap--NotesPayableCurrent_c20220610__srt--TitleOfIndividualAxis__custom--ThirdParty3Member_pp0p0" title="Notes payble">7,630</span> to a third party. The note matures in 6 months and bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220601__20220610__srt--TitleOfIndividualAxis__custom--ThirdParty3Member_z8vgSK2TAGkc" title="Interest rate">10</span>% per annum. As of March 31, 2023, there is $<span id="xdx_903_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20230331__srt--TitleOfIndividualAxis__custom--ThirdParty3Member_zPhtboQl5439" title="Interest accrued">615</span> of interest accrued on this note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 18, 2022, the Company issued a note payable for $<span id="xdx_90C_eus-gaap--NotesPayableCurrent_c20221018__srt--TitleOfIndividualAxis__custom--ThirdParty4Member_pp0p0" title="Notes payble">25,000</span> to a third party. The note matures in one year and bears interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20221001__20221018__srt--TitleOfIndividualAxis__custom--ThirdParty4Member_z4oOxfF1eHCb" title="Interest rate">8</span>% per annum. As of March 31, 2023, there is $<span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20230331__srt--TitleOfIndividualAxis__custom--ThirdParty4Member_zIbIENJKvu9d" title="Interest accrued">899</span> of interest accrued on this note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 6, 2023, the Company issued a note payable for $<span id="xdx_90D_eus-gaap--NotesPayableCurrent_c20230106__srt--TitleOfIndividualAxis__custom--ThirdParty5Member_pp0p0" title="Notes payble">15,000</span> to a third party. The note matures on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20230101__20230106__srt--TitleOfIndividualAxis__custom--ThirdParty5Member" title="Maturity date">July 6, 2023</span>, and bears interest at <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230101__20230106__srt--TitleOfIndividualAxis__custom--ThirdParty5Member_zZweQvh5NdGi" title="Interest rate">8.5</span>% per annum. As of March 31, 2023, there is $<span id="xdx_900_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20230331__srt--TitleOfIndividualAxis__custom--ThirdParty5Member_z8bZM7tC0DO1" title="Interest accrued">293</span> of interest accrued on this note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 13, 2023, the Company issued a note payable for $<span id="xdx_90C_eus-gaap--NotesPayableCurrent_c20230313__srt--TitleOfIndividualAxis__custom--ThirdParty6Member_pp0p0" title="Notes payble">12,000</span> to a third party. The note matures on <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20230301__20230313__srt--TitleOfIndividualAxis__custom--ThirdParty6Member" title="Maturity date">September 13, 2023</span>, and bears interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230301__20230313__srt--TitleOfIndividualAxis__custom--ThirdParty6Member_zCuRfQNx9Qvd" title="Interest rate">8.5</span>% per annum. As of March 31, 2023, there is $<span id="xdx_901_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20230331__srt--TitleOfIndividualAxis__custom--ThirdParty6Member_zIyZNe06D7A2" title="Interest accrued">50</span> of interest accrued on this note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 10000 0.06 519 10000 0.06 518 7630 0.10 615 25000 0.08 899 15000 2023-07-06 0.085 293 12000 2023-09-13 0.085 50 <p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zAWVPvD7wfpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 5 – <span id="xdx_823_zNuNuOujw3si">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, Forty 7 Select Holdings LLC (“Forty 7”) advanced the Company $<span id="xdx_90A_ecustom--DueFromRelatedParty_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--Forty7SelectHoldingsLLCMember_zkSbywGTOcv9" title="Due from Related Parties">27,643</span>, to pay for general operating expenses. Forty 7 is controlled by Greg Shockey, an existing shareholder of the Company. As of March 31, 2023, the balance due to Forty 7 is $<span id="xdx_909_ecustom--DueToRelatedParty_iI_pp0p0_c20230331__dei--LegalEntityAxis__custom--Forty7SelectHoldingsLLCMember_zTBAvYb3Pks8" title="Due to related party">50,268</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 10, 2023, the Company issued a note payable for $<span id="xdx_90C_eus-gaap--NotesPayable_c20230110__dei--LegalEntityAxis__custom--Forty7SelectHoldingsLLCMember_pp0p0" title="Note payable">15,000</span> to Forty 7. The note matures on <span id="xdx_904_eus-gaap--RelatedPartyTransactionDate_c20230101__20230110__dei--LegalEntityAxis__custom--Forty7SelectHoldingsLLCMember" title="Maturity date">July 10, 2023</span>, and bears interest at <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230101__20230110__dei--LegalEntityAxis__custom--Forty7SelectHoldingsLLCMember_zUEkfOKLJOM1" title="Interest rate">8.5</span>% per annum. As of March 31, 2023, there is $<span id="xdx_90D_eus-gaap--InterestPayableCurrent_c20230331__dei--LegalEntityAxis__custom--Forty7SelectHoldingsLLCMember_pp0p0" title="Accrued interest">279</span> of interest accrued on this note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Refer to Note 7 for options to purchase shares of common stock issued to related parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> 27643 50268 15000 2023-07-10 0.085 279 <p id="xdx_806_eus-gaap--PreferredStockTextBlock_z78Ybgncu9E5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 6 – <span id="xdx_825_z26TpC29qtcf">PREFERRED STOCK</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has designated <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zu2Xt37ZM7g1" title="Preferred stock, shares authorized">1,000</span> shares of Series A Preferred Stock. The shares of Series A Preferred Stock have a par value of $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zXAUsjFJPsj5" title="Preferred stock, par value">0.0001</span> per share. The Series A Preferred Shares do not have a dividend rate or liquidation preference and are not convertible into shares of common stock. <span id="xdx_904_eus-gaap--PreferredStockVotingRights_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zjSKfteE7S85" title="Preferred stock voting rights">Series A Preferred Stock, voting together as a class, have the right to vote 60% of the Company’s voting shares</span> on any and all shareholder matters (the “Majority Voting Rights”). Additionally, the Company shall not adopt any amendments to the Company’s Bylaws, Articles of Incorporation, as amended, make any changes to the Certificate of Designations establishing the Series A Preferred Stock, or effect any reclassification of the Series A Preferred Stock, without the affirmative vote of at least a majority of the outstanding shares of Series A Preferred Stock. However, the Company may, by any means authorized by law and without any vote of the holders of shares of Series A Preferred Stock, make technical, corrective, administrative or similar changes to such Certificate of Designations that do not, individually or in the aggregate, adversely affect the rights or preferences of the holders of shares of Series A Preferred Stock. Other than the Majority Voting Rights, the Series A Preferred Stock does not have any other dividend, liquidation, conversion, or redemption rights, whatsoever.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> 1000 0.0001 Series A Preferred Stock, voting together as a class, have the right to vote 60% of the Company’s voting shares <p id="xdx_80E_ecustom--OptionsTextBlock_zRsWGMXreCL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 – <span id="xdx_829_zSSasAyGscp3">OPTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the first quarter of 2022, the Company entered into an Employment Agreement with Thomas Spruce, an officer and director of the Company. This Employment Agreement has a term of 2 years and automatically renews for an additional 6-month term unless terminated earlier. This agreement is terminable by each of the parties upon written notice. Under this Employment Agreement, the Company pays a base salary of $1.00 per year and issued options to purchase 500,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of two years and expire 10 years from the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective April 12, 2022, the Company entered into an Advisory Agreement with Greg Shockey, an affiliate of the Company and service provider. Under this Advisory Agreement, the Company issued options to purchase 240,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective April 12, 2022, the Company entered into an Advisory Agreement with Danijella Dragas, a third-party service provider. Under this Advisory Agreement, the Company issued options to purchase 240,000 restricted shares of the Company’s common stock at a strike price of $0.39 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant. On March 23, 2023, the Advisory Agreement was cancelled, thereby terminating Danijella Dragas and forfeiting 60,000 unvested options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 27, 2022, the Company entered into an Addendum to Employment Agreement with Thomas Spruce, which granted Mr. Spruce options to purchase an additional 250,000 restricted shares of the Company’s common stock at a strike price of $0.15 per share. The options vest immediately from the date of the grant and expire 10 years from the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 16, 2022, the Company entered into an Employment Agreement with Jim Kellogg, which granted Mr. Kellogg options to purchase 300,000 restricted shares of the Company’s common stock at a strike price of $0.10 per share. The options vest over a period of 1 year contingent upon service and expire 10 years from the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 1, 2023, the Company entered into an Advisor Agreement with Greg Shockey, which supersedes his previous Advisor Agreement with the Company, whereby, in exchange for business development and strategy consulting, investor relations, and facilitating meetings with targeted investors, as well as other services, the Company agreed to issue Greg Shockey options to purchase 60,000 restricted shares of common stock at signing and an additional 1,200,000 shares of restricted common stock every year thereafter for three years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 1, 2023, Peter Hager was appointed as the Company’s President and Chief Executive Officer. Per the terms of the employment agreement Mr. Hager was granted options to purchase 6,400,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $0.06 per share, vesting in installments of 500,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and 1,000,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 1, 2033, Thomas Spruce was appointed as the Company’s Secretary and Chief Operations Officer. Per the terms of the employment agreement Mr. Spruce was granted options to purchase 1,750,000 restricted shares of the Company’s common stock, at the commencement of his initial term of services, for an exercise price $0.06 per share, vesting with respect to the first 250,000 shares on February 1, 2023 and vesting with respect to the remaining 1,500,000 shares in installments of 125,000 shares per fiscal quarter with the first vesting date of April 1, 2023 and 250,000 options to purchase restricted shares of the Company’s common stock, at the commencement of his first renewal term of service.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock_zoxEtbOfuDg7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 82%"><span id="xdx_8B2_zE3PXFibHM04" style="display: none">Options issued with the following inputs</span></td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 15%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Options issued in the three months ended March 31, 2023, with the following inputs:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%">Options</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_c20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_pdd" title="Options">11,810,000</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Share price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharePrice_c20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_pdd" title="Share price">0.066</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_pdd" title="Exercise Price">0.06</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_z57SrSvZytR7" title="Warrant term">10</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_zRVz4VtPccY7" title="Volatility">209.39</span></td><td style="white-space: nowrap; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_zwpc1KhLS8W8" title="Risk Free Interest Rate">3.39</span></td><td style="white-space: nowrap; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dividend rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_za461hs758x2" title="Dividend rate"><span style="-sec-ix-hidden: xdx2ixbrl0434">—</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zlt5WbIS4Brg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A summary of the status of the Company’s outstanding stock options and changes during the year is presented below:</p> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfCommonStockOptionsOutstandingRollForwardTableTextBlock_z8ONUWBXPfZe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt"><span id="xdx_8B7_zxErgLv1Poh2" style="display: none">Schedule of options activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contract<br/> Term</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Aggregate <br/> Intrinsic <br/> Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zr8P9nAEvkRe" style="text-align: right" title="Number of options outstanding at beginning"><span style="-sec-ix-hidden: xdx2ixbrl0438">—</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zGUoCedIAlGl" style="text-align: right" title="Weighted average exercise pricec at Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0440">—</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; width: 40%">Granted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zYOu9fd6WpQf" style="width: 12%; text-align: right" title="Number of options, Granted">2,030,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231_pdd" style="width: 12%; text-align: right" title="Weighted average exercise price, Granted">0.36</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--OptionsOutstandingGrantedTerm_dtY_c20220101__20221231_zMnH0ck0EpLl" title="Weighted average remaining contract term, Granted">10</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_z627PLBHICB2" style="text-align: right" title="Number of options, Cancelled">(250,000</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230331_zIArBfhdWUyd" style="text-align: right" title="Number of options outstanding at beginning">1,780,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230331_zMWFGNPdqNYj" style="text-align: right" title="Weighted average exercise pricec at Beginning">0.35</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--OptionsOutstandingTerm_dtY_c20220101__20221231_z5t7wGH02K2l" title="Weighted average remaining contract term at beginning">9.81</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331_zHLXFOE94DT1" style="text-align: right" title="Number of options, Granted">11,810,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331_pdd" style="text-align: right" title="Weighted average exercise price, Granted">0.06</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--OptionsOutstandingGrantedTerm_dtY_c20230101__20230331_z5r67ELEXycd" title="Weighted average remaining contract term, Granted">10</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-align: left">Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230331_zyMWjUFHC2T7" style="text-align: right">(60,000</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; text-align: left; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230331_zFJFAU53wv64" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options outstanding at ending">13,530,000</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230331_zd9vWUcAy4vi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise pricec at ending">0.09</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--OptionsOutstandingTerm_dtY_c20230101__20230331_zt9nPZYXm3M1" title="Weighted average remaining contract term at ending">9.75</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230331_ztnXIN9JFzvd" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options exercisable (in shares)">2,220,000</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20230331_zms7IiOSGx2c" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercisable">0.24</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--WeightedAverageRemainingContractTermExercisable1_dtY_c20230101__20230331_zrqesXELtoI8" title="Weighted average remaining contract term, exercisable">9.34</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zfsJny47fP69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zgOyDed1aDDc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OPTIONS (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span id="xdx_8B8_z1dFVWmEOx1h" style="display: none">Schedule of stock options activity number of shares</span></td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 25%; text-align: center"><b>Range of Exercise <br/> Prices</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; text-align: center"><b>Number Outstanding <br/> 3/31/2023</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; text-align: center"><b>Weighted Average <br/> Remaining <br/> Contractual Life</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="white-space: nowrap; width: 24%; text-align: center"><b>Weighted Average <br/> Exercise Price</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__srt--RangeAxis__srt--MinimumMember__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_pdd" title="Exercise Price">0.06</span> – <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__srt--RangeAxis__srt--MaximumMember__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_pdd" title="Exercise Price">0.39</span></td> <td style="white-space: nowrap"> </td> <td style="text-align: center"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_pdd" title="Class of Warrant or Right, Outstanding">13,590,000</span></td> <td style="white-space: nowrap"> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_zipSf5kwlOV3" title="Warrants and Rights Outstanding, Term">9.75</span> years</td> <td style="white-space: nowrap"> </td> <td style="text-align: center">$<span id="xdx_906_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_pdd" title="Weighted average exercise price">0.09</span></td></tr> </table> <p id="xdx_8A7_z5NIcwsTLxK4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock_zoxEtbOfuDg7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 82%"><span id="xdx_8B2_zE3PXFibHM04" style="display: none">Options issued with the following inputs</span></td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 15%"> </td><td style="white-space: nowrap; text-align: left; width: 1%"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Options issued in the three months ended March 31, 2023, with the following inputs:</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%">Options</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_c20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_pdd" title="Options">11,810,000</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Share price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharePrice_c20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_pdd" title="Share price">0.066</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_pdd" title="Exercise Price">0.06</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_z57SrSvZytR7" title="Warrant term">10</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_zRVz4VtPccY7" title="Volatility">209.39</span></td><td style="white-space: nowrap; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk Free Interest Rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_zwpc1KhLS8W8" title="Risk Free Interest Rate">3.39</span></td><td style="white-space: nowrap; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dividend rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20230331__us-gaap--AwardTypeAxis__custom--OptionsMember_za461hs758x2" title="Dividend rate"><span style="-sec-ix-hidden: xdx2ixbrl0434">—</span></span></td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 11810000 0.066 0.06 P10Y 2.0939 0.0339 <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfCommonStockOptionsOutstandingRollForwardTableTextBlock_z8ONUWBXPfZe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPTIONS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt"><span id="xdx_8B7_zxErgLv1Poh2" style="display: none">Schedule of options activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contract<br/> Term</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Aggregate <br/> Intrinsic <br/> Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zr8P9nAEvkRe" style="text-align: right" title="Number of options outstanding at beginning"><span style="-sec-ix-hidden: xdx2ixbrl0438">—</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zGUoCedIAlGl" style="text-align: right" title="Weighted average exercise pricec at Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0440">—</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; width: 40%">Granted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zYOu9fd6WpQf" style="width: 12%; text-align: right" title="Number of options, Granted">2,030,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231_pdd" style="width: 12%; text-align: right" title="Weighted average exercise price, Granted">0.36</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--OptionsOutstandingGrantedTerm_dtY_c20220101__20221231_zMnH0ck0EpLl" title="Weighted average remaining contract term, Granted">10</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_z627PLBHICB2" style="text-align: right" title="Number of options, Cancelled">(250,000</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230331_zIArBfhdWUyd" style="text-align: right" title="Number of options outstanding at beginning">1,780,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230331_zMWFGNPdqNYj" style="text-align: right" title="Weighted average exercise pricec at Beginning">0.35</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--OptionsOutstandingTerm_dtY_c20220101__20221231_z5t7wGH02K2l" title="Weighted average remaining contract term at beginning">9.81</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331_zHLXFOE94DT1" style="text-align: right" title="Number of options, Granted">11,810,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331_pdd" style="text-align: right" title="Weighted average exercise price, Granted">0.06</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--OptionsOutstandingGrantedTerm_dtY_c20230101__20230331_z5r67ELEXycd" title="Weighted average remaining contract term, Granted">10</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-align: left">Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230331_zyMWjUFHC2T7" style="text-align: right">(60,000</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; text-align: left; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230331_zFJFAU53wv64" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options outstanding at ending">13,530,000</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230331_zd9vWUcAy4vi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise pricec at ending">0.09</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--OptionsOutstandingTerm_dtY_c20230101__20230331_zt9nPZYXm3M1" title="Weighted average remaining contract term at ending">9.75</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230331_ztnXIN9JFzvd" style="border-bottom: Black 1pt solid; text-align: right" title="Number of options exercisable (in shares)">2,220,000</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20230331_zms7IiOSGx2c" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price exercisable">0.24</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_ecustom--WeightedAverageRemainingContractTermExercisable1_dtY_c20230101__20230331_zrqesXELtoI8" title="Weighted average remaining contract term, exercisable">9.34</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> </table> 2030000 0.36 P10Y 250000 1780000 0.35 P9Y9M21D 11810000 0.06 P10Y 60000 13530000 0.09 P9Y9M 2220000 0.24 P9Y4M2D <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zgOyDed1aDDc" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OPTIONS (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span id="xdx_8B8_z1dFVWmEOx1h" style="display: none">Schedule of stock options activity number of shares</span></td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 25%; text-align: center"><b>Range of Exercise <br/> Prices</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; text-align: center"><b>Number Outstanding <br/> 3/31/2023</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; text-align: center"><b>Weighted Average <br/> Remaining <br/> Contractual Life</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="white-space: nowrap; width: 24%; text-align: center"><b>Weighted Average <br/> Exercise Price</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__srt--RangeAxis__srt--MinimumMember__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_pdd" title="Exercise Price">0.06</span> – <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__srt--RangeAxis__srt--MaximumMember__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_pdd" title="Exercise Price">0.39</span></td> <td style="white-space: nowrap"> </td> <td style="text-align: center"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_pdd" title="Class of Warrant or Right, Outstanding">13,590,000</span></td> <td style="white-space: nowrap"> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_zipSf5kwlOV3" title="Warrants and Rights Outstanding, Term">9.75</span> years</td> <td style="white-space: nowrap"> </td> <td style="text-align: center">$<span id="xdx_906_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--OptionMember_pdd" title="Weighted average exercise price">0.09</span></td></tr> </table> 0.06 0.39 13590000 P9Y9M 0.09 <p id="xdx_802_ecustom--WarrantsTextBlock_zp9QhsLBVdmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 – <span id="xdx_827_zn9d9AONocb6">WARRANTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A summary of the status of the Company’s outstanding stock warrants and changes during the year is presented below:</p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zAgSt11eS7t3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt"><span style="display: none"><span id="xdx_8B4_ze9xnS7whdzi">Schedule of common stock outstanding roll forward</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contract<br/> Term</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Aggregate <br/> Intrinsic <br/> Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20220101__20221231_zTVvue4FqZT1" style="width: 12%; text-align: right" title="Number of warrants outstanding at beginning">153,503</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20221231_zmlVptWjod1k" style="width: 12%; text-align: right" title="Weighted average exercise price at beginning">0.25</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iS_dtY_c20220101__20221231_zGr3YwPrZx96" title="Weighted average remaining contract term at beginning">6.92</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231_pdd" title="Number of warrants outstanding, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0497">—</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20220101__20221231_zDwp8XwjabM7" style="text-align: right" title="Number of warrants outstanding outstanding at ending">153,503</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20221231_ztJAQdyC0y2g" style="text-align: right" title="Weighted average exercise price at ending">0.25</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iE_dtY_c20220101__20221231_zcjE7W0iXDuf" title="Weighted average remaining contract term at ending">5.92</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercisable at March 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--NumberOfWarrantsExercisable_c20230101__20230331_zKuDGJ9gKq26" style="text-align: right" title="Number of warrants exercisable (in shares)">153,503</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--WeightedAverageExercisePriceExercisable_c20230101__20230331_pdd" style="text-align: right" title="Weighted average exercise price exercisable">0.25</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--WeightedAverageRemainingContractTermExercisable_dtY_c20230101__20230331_zt0EeBBWl92b" title="Weighted average remaining contract term, exercisable">5.67</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zKWewsh6sNdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zLVzJxOlZrAi" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - WARRANTS (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span id="xdx_8BD_zeUuxD0BuORh" style="display: none">Schedule of weighted average number of shares</span></td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 25%; text-align: center"><b>Range of Exercise <br/> Prices</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; text-align: center"><b>Number Outstanding <br/> 3/31/2023</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; text-align: center"><b>Weighted Average <br/> Remaining <br/> Contractual Life</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="white-space: nowrap; width: 24%; text-align: center"><b>Weighted Average <br/> Exercise Price</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">$<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Exercise Price">0.25</span></td> <td style="white-space: nowrap"> </td> <td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" style="text-align: center" title="Number outstanding">153,503</td> <td style="white-space: nowrap"> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zcxomSSuhmm2" title="Weighted average remaining contractual life (years)">5.67</span> years</td> <td style="white-space: nowrap"> </td> <td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" style="text-align: center" title="Weighted average exercise price">$0.25</td></tr> </table> <p id="xdx_8AB_zFwsUnszrrpj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_zAgSt11eS7t3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt"><span style="display: none"><span id="xdx_8B4_ze9xnS7whdzi">Schedule of common stock outstanding roll forward</span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Number of<br/> Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contract<br/> Term</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Aggregate <br/> Intrinsic <br/> Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20220101__20221231_zTVvue4FqZT1" style="width: 12%; text-align: right" title="Number of warrants outstanding at beginning">153,503</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20221231_zmlVptWjod1k" style="width: 12%; text-align: right" title="Weighted average exercise price at beginning">0.25</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iS_dtY_c20220101__20221231_zGr3YwPrZx96" title="Weighted average remaining contract term at beginning">6.92</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231_pdd" title="Number of warrants outstanding, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0497">—</span></span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20220101__20221231_zDwp8XwjabM7" style="text-align: right" title="Number of warrants outstanding outstanding at ending">153,503</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20221231_ztJAQdyC0y2g" style="text-align: right" title="Weighted average exercise price at ending">0.25</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iE_dtY_c20220101__20221231_zcjE7W0iXDuf" title="Weighted average remaining contract term at ending">5.92</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Expired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; padding-bottom: 1pt">Exercised</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercisable at March 31, 2023</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--NumberOfWarrantsExercisable_c20230101__20230331_zKuDGJ9gKq26" style="text-align: right" title="Number of warrants exercisable (in shares)">153,503</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--WeightedAverageExercisePriceExercisable_c20230101__20230331_pdd" style="text-align: right" title="Weighted average exercise price exercisable">0.25</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--WeightedAverageRemainingContractTermExercisable_dtY_c20230101__20230331_zt0EeBBWl92b" title="Weighted average remaining contract term, exercisable">5.67</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 153503 0.25 P6Y11M1D 153503 0.25 P5Y11M1D 153503 0.25 P5Y8M1D <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zLVzJxOlZrAi" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - WARRANTS (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span id="xdx_8BD_zeUuxD0BuORh" style="display: none">Schedule of weighted average number of shares</span></td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: center"> </td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 25%; text-align: center"><b>Range of Exercise <br/> Prices</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; text-align: center"><b>Number Outstanding <br/> 3/31/2023</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; text-align: center"><b>Weighted Average <br/> Remaining <br/> Contractual Life</b></td> <td style="white-space: nowrap; width: 1%"> </td> <td style="white-space: nowrap; width: 24%; text-align: center"><b>Weighted Average <br/> Exercise Price</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">$<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Exercise Price">0.25</span></td> <td style="white-space: nowrap"> </td> <td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" style="text-align: center" title="Number outstanding">153,503</td> <td style="white-space: nowrap"> </td> <td style="text-align: center"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zcxomSSuhmm2" title="Weighted average remaining contractual life (years)">5.67</span> years</td> <td style="white-space: nowrap"> </td> <td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights_c20230331__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" style="text-align: center" title="Weighted average exercise price">$0.25</td></tr> </table> 0.25 153503 P5Y8M1D 0.25 <p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zeJpymMSH3a7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 – <span id="xdx_82D_zNCm7HyO6qud">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were issued and has determined that there are no material subsequent events to disclose in these financial statements.</p> EXCEL 40 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 42 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 70 134 1 false 19 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://cannassist.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS (UNAUDITED) Sheet http://cannassist.com/role/BalanceSheets BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://cannassist.com/role/BalanceSheetsParenthetical BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://cannassist.com/role/StatementsOfOperations STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - STATEMENTS OF CHANGES OF STOCKHOLDERS' DEFICIT (UNAUDITED) Sheet http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit STATEMENTS OF CHANGES OF STOCKHOLDERS' DEFICIT (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://cannassist.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 6 false false R7.htm 00000007 - Disclosure - DESCRIPTION OF BUSINESS AND HISTORY Sheet http://cannassist.com/role/DescriptionOfBusinessAndHistory DESCRIPTION OF BUSINESS AND HISTORY Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://cannassist.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://cannassist.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - NOTES PAYABLE Notes http://cannassist.com/role/NotesPayable NOTES PAYABLE Notes 10 false false R11.htm 00000011 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://cannassist.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 00000012 - Disclosure - PREFERRED STOCK Sheet http://cannassist.com/role/PreferredStock PREFERRED STOCK Notes 12 false false R13.htm 00000013 - Disclosure - OPTIONS Sheet http://cannassist.com/role/Options OPTIONS Notes 13 false false R14.htm 00000014 - Disclosure - WARRANTS Sheet http://cannassist.com/role/Warrants WARRANTS Notes 14 false false R15.htm 00000015 - Disclosure - SUBSEQUENT EVENTS Sheet http://cannassist.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 00000017 - Disclosure - OPTIONS (Tables) Sheet http://cannassist.com/role/OptionsTables OPTIONS (Tables) Tables http://cannassist.com/role/Options 17 false false R18.htm 00000018 - Disclosure - WARRANTS (Tables) Sheet http://cannassist.com/role/WarrantsTables WARRANTS (Tables) Tables http://cannassist.com/role/Warrants 18 false false R19.htm 00000019 - Disclosure - DESCRIPTION OF BUSINESS AND HISTORY (Details Narrative) Sheet http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative DESCRIPTION OF BUSINESS AND HISTORY (Details Narrative) Details http://cannassist.com/role/DescriptionOfBusinessAndHistory 19 false false R20.htm 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesPolicies 20 false false R21.htm 00000021 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://cannassist.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://cannassist.com/role/GoingConcern 21 false false R22.htm 00000022 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://cannassist.com/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) Details http://cannassist.com/role/NotesPayable 22 false false R23.htm 00000023 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://cannassist.com/role/RelatedPartyTransactions 23 false false R24.htm 00000024 - Disclosure - PREFERRED STOCK (Details Narrative) Sheet http://cannassist.com/role/PreferredStockDetailsNarrative PREFERRED STOCK (Details Narrative) Details http://cannassist.com/role/PreferredStock 24 false false R25.htm 00000025 - Disclosure - OPTIONS (Details) Sheet http://cannassist.com/role/OptionsDetails OPTIONS (Details) Details http://cannassist.com/role/OptionsTables 25 false false R26.htm 00000026 - Disclosure - OPTIONS (Details 1) Sheet http://cannassist.com/role/OptionsDetails1 OPTIONS (Details 1) Details http://cannassist.com/role/OptionsTables 26 false false R27.htm 00000027 - Disclosure - OPTIONS (Details 2) Sheet http://cannassist.com/role/OptionsDetails2 OPTIONS (Details 2) Details http://cannassist.com/role/OptionsTables 27 false false R28.htm 00000028 - Disclosure - WARRANTS (Details) Sheet http://cannassist.com/role/WarrantsDetails WARRANTS (Details) Details http://cannassist.com/role/WarrantsTables 28 false false R29.htm 00000029 - Disclosure - WARRANTS (Details 1) Sheet http://cannassist.com/role/WarrantsDetails1 WARRANTS (Details 1) Details http://cannassist.com/role/WarrantsTables 29 false false All Reports Book All Reports j5923110q.htm ex31_1.htm ex31_2.htm ex32_1.htm xesp-20230331.xsd xesp-20230331_cal.xml xesp-20230331_def.xml xesp-20230331_lab.xml xesp-20230331_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 45 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "j5923110q.htm": { "axisCustom": 0, "axisStandard": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 240, "http://xbrl.sec.gov/dei/2023": 27 }, "contextCount": 70, "dts": { "calculationLink": { "local": [ "xesp-20230331_cal.xml" ] }, "definitionLink": { "local": [ "xesp-20230331_def.xml" ] }, "inline": { "local": [ "j5923110q.htm" ] }, "labelLink": { "local": [ "xesp-20230331_lab.xml" ] }, "presentationLink": { "local": [ "xesp-20230331_pre.xml" ] }, "schema": { "local": [ "xesp-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 235, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 41, "http://xbrl.sec.gov/dei/2023": 5, "total": 46 }, "keyCustom": 14, "keyStandard": 120, "memberCustom": 9, "memberStandard": 10, "nsprefix": "xesp", "nsuri": "http://cannassist.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://cannassist.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "xesp:NotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - NOTES PAYABLE", "menuCat": "Notes", "order": "10", "role": "http://cannassist.com/role/NotesPayable", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "xesp:NotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "11", "role": "http://cannassist.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - PREFERRED STOCK", "menuCat": "Notes", "order": "12", "role": "http://cannassist.com/role/PreferredStock", "shortName": "PREFERRED STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "xesp:OptionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - OPTIONS", "menuCat": "Notes", "order": "13", "role": "http://cannassist.com/role/Options", "shortName": "OPTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "xesp:OptionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "xesp:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - WARRANTS", "menuCat": "Notes", "order": "14", "role": "http://cannassist.com/role/Warrants", "shortName": "WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "xesp:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "15", "role": "http://cannassist.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "16", "role": "http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "xesp:OptionsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - OPTIONS (Tables)", "menuCat": "Tables", "order": "17", "role": "http://cannassist.com/role/OptionsTables", "shortName": "OPTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "xesp:OptionsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "xesp:WarrantsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - WARRANTS (Tables)", "menuCat": "Tables", "order": "18", "role": "http://cannassist.com/role/WarrantsTables", "shortName": "WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "xesp:WarrantsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2021-10-072021-10-09", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - DESCRIPTION OF BUSINESS AND HISTORY (Details Narrative)", "menuCat": "Details", "order": "19", "role": "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative", "shortName": "DESCRIPTION OF BUSINESS AND HISTORY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2021-10-072021-10-09", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - BALANCE SHEETS (UNAUDITED)", "menuCat": "Statements", "order": "2", "role": "http://cannassist.com/role/BalanceSheets", "shortName": "BALANCE SHEETS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "20", "role": "http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - GOING CONCERN (Details Narrative)", "menuCat": "Details", "order": "21", "role": "http://cannassist.com/role/GoingConcernDetailsNarrative", "shortName": "GOING CONCERN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R22": { "firstAnchor": { "ancestors": [ "span", "p", "xesp:NotesPayableTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2022-05-19_custom_ThirdParty1Member", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - NOTES PAYABLE (Details Narrative)", "menuCat": "Details", "order": "22", "role": "http://cannassist.com/role/NotesPayableDetailsNarrative", "shortName": "NOTES PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "xesp:NotesPayableTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2022-05-19_custom_ThirdParty1Member", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "xesp:DueToRelatedParty", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "23", "role": "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2022-12-31_custom_Forty7SelectHoldingsLLCMember", "decimals": "0", "lang": null, "name": "xesp:DueFromRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - PREFERRED STOCK (Details Narrative)", "menuCat": "Details", "order": "24", "role": "http://cannassist.com/role/PreferredStockDetailsNarrative", "shortName": "PREFERRED STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-012023-03-31_us-gaap_SeriesAPreferredStockMember", "decimals": null, "lang": "en-US", "name": "us-gaap:PreferredStockVotingRights", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2021-10-09", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - OPTIONS (Details)", "menuCat": "Details", "order": "25", "role": "http://cannassist.com/role/OptionsDetails", "shortName": "OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "xesp:OptionsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31_custom_OptionsMember", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "xesp:ScheduleOfCommonStockOptionsOutstandingRollForwardTableTextBlock", "xesp:OptionsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - OPTIONS (Details 1)", "menuCat": "Details", "order": "26", "role": "http://cannassist.com/role/OptionsDetails1", "shortName": "OPTIONS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "xesp:ScheduleOfCommonStockOptionsOutstandingRollForwardTableTextBlock", "xesp:OptionsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "xesp:WarrantsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - OPTIONS (Details 2)", "menuCat": "Details", "order": "27", "role": "http://cannassist.com/role/OptionsDetails2", "shortName": "OPTIONS (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "xesp:OptionsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31_us-gaap_OptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "xesp:WarrantsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - WARRANTS (Details)", "menuCat": "Details", "order": "28", "role": "http://cannassist.com/role/WarrantsDetails", "shortName": "WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "xesp:WarrantsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "xesp:WarrantsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - WARRANTS (Details 1)", "menuCat": "Details", "order": "29", "role": "http://cannassist.com/role/WarrantsDetails1", "shortName": "WARRANTS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "xesp:WarrantsTextBlock", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31_us-gaap_WarrantMember", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - BALANCE SHEETS (UNAUDITED) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://cannassist.com/role/BalanceSheetsParenthetical", "shortName": "BALANCE SHEETS (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - STATEMENTS OF OPERATIONS (UNAUDITED)", "menuCat": "Statements", "order": "4", "role": "http://cannassist.com/role/StatementsOfOperations", "shortName": "STATEMENTS OF OPERATIONS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - STATEMENTS OF CHANGES OF STOCKHOLDERS' DEFICIT (UNAUDITED)", "menuCat": "Statements", "order": "5", "role": "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit", "shortName": "STATEMENTS OF CHANGES OF STOCKHOLDERS' DEFICIT (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - STATEMENTS OF CASH FLOWS (UNAUDITED)", "menuCat": "Statements", "order": "6", "role": "http://cannassist.com/role/StatementsOfCashFlows", "shortName": "STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS AND HISTORY", "menuCat": "Notes", "order": "7", "role": "http://cannassist.com/role/DescriptionOfBusinessAndHistory", "shortName": "DESCRIPTION OF BUSINESS AND HISTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://cannassist.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - GOING CONCERN", "menuCat": "Notes", "order": "9", "role": "http://cannassist.com/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "j5923110q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 19, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r382", "r384", "r385" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://cannassist.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r141", "r142", "r143", "r144", "r165", "r234", "r248", "r277", "r278", "r334", "r335", "r336", "r337", "r341", "r347", "r348", "r352", "r354", "r355", "r359", "r408", "r416", "r417", "r418", "r420", "r421", "r422" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails2" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r141", "r142", "r143", "r144", "r165", "r234", "r248", "r277", "r278", "r334", "r335", "r336", "r337", "r341", "r347", "r348", "r352", "r354", "r355", "r359", "r408", "r416", "r417", "r418", "r420", "r421", "r422" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails2" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r141", "r142", "r143", "r144", "r164", "r165", "r190", "r191", "r192", "r233", "r234", "r248", "r277", "r278", "r334", "r335", "r336", "r337", "r341", "r347", "r348", "r352", "r354", "r355", "r359", "r362", "r404", "r408", "r417", "r418", "r420", "r421", "r422" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails2" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r141", "r142", "r143", "r144", "r164", "r165", "r190", "r191", "r192", "r233", "r234", "r248", "r277", "r278", "r334", "r335", "r336", "r337", "r341", "r347", "r348", "r352", "r354", "r355", "r359", "r362", "r404", "r408", "r417", "r418", "r420", "r421", "r422" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails2" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r402", "r413" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative", "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative", "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r7", "r358" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable and accruals" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Paid For:" } } }, "localname": "AdditionalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r43", "r358", "r425" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r194", "r195", "r196", "r264", "r398", "r399", "r400", "r410", "r429" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r64", "r84", "r103", "r128", "r132", "r134", "r136", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r203", "r207", "r217", "r237", "r299", "r358", "r370", "r406", "r407", "r414" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r39", "r55", "r56" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "DESCRIPTION OF BUSINESS AND HISTORY" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistory" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r71", "r239", "r275", "r294", "r358", "r370", "r392" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r15", "r83", "r349" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r15", "r52", "r101" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r1", "r52" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r79", "r85", "r86", "r87", "r103", "r119", "r120", "r123", "r124", "r126", "r127", "r136", "r145", "r147", "r148", "r149", "r152", "r153", "r155", "r156", "r158", "r159", "r161", "r217", "r255", "r256", "r257", "r258", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r276", "r286", "r308", "r329", "r342", "r343", "r344", "r345", "r346", "r391", "r396", "r401" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets", "http://cannassist.com/role/BalanceSheetsParenthetical", "http://cannassist.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r85", "r86", "r87", "r126", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r255", "r256", "r257", "r258", "r354", "r391", "r396" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails2", "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails2", "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise Price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails", "http://cannassist.com/role/OptionsDetails2", "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Number outstanding", "verboseLabel": "Options" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails", "http://cannassist.com/role/OptionsDetails2", "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r12", "r37", "r238", "r285" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r398", "r399", "r410", "r424", "r429" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r42", "r286" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r3", "r42", "r286", "r305", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r42", "r241", "r358" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, $0.0001 par value, 100,000,000 shares authorized; 21,416,001 shares issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r38", "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r18", "r19", "r20" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Number of shares converted (in shares)" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r11", "r35", "r154" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative", "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r78", "r353", "r411" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative", "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r3", "r80", "r91", "r92", "r93", "r104", "r105", "r106", "r108", "r113", "r115", "r125", "r137", "r138", "r163", "r194", "r195", "r196", "r198", "r199", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r218", "r219", "r220", "r221", "r222", "r223", "r225", "r249", "r250", "r251", "r264", "r329" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r50", "r310" ], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r48", "r67", "r128", "r131", "r133", "r135", "r236", "r244", "r351" ], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r70", "r77", "r114", "r115", "r130", "r197", "r200", "r247" ], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r17" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r2" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accruals" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in Operating Assets and Liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r2" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r36", "r69", "r94", "r129", "r224", "r314", "r368", "r426" ], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r96", "r99", "r100" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r9" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest accrued", "verboseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative", "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r47", "r66", "r243", "r358", "r397", "r403", "r412" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r10", "r82", "r103", "r136", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r204", "r207", "r208", "r217", "r358", "r406", "r414", "r415" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r6", "r65", "r423" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Loans payable" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from Financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Cash flows from Investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r52", "r53", "r54" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r49", "r54", "r68", "r81", "r89", "r90", "r93", "r103", "r107", "r109", "r110", "r111", "r112", "r114", "r115", "r121", "r128", "r131", "r133", "r135", "r136", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r216", "r217", "r246", "r307", "r327", "r328", "r351", "r368", "r406" ], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r95", "r109", "r110", "r111", "r112", "r116", "r117", "r122", "r124", "r128", "r131", "r133", "r135", "r351" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently issued accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1": { "auth_ref": [ "r18", "r19", "r20" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of debt" } } }, "localname": "NoncashOrPartNoncashAcquisitionDebtAssumed1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r51" ], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expense" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other expense:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r6", "r65", "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Note payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r8" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payble" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r128", "r131", "r133", "r135", "r351" ], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OptionMember": { "auth_ref": [ "r63", "r295", "r300", "r317", "r323", "r338", "r339", "r340", "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).", "label": "Options Held [Member]" } } }, "localname": "OptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r360", "r361", "r364", "r365", "r366", "r367", "r424", "r429" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r41", "r155" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheetsParenthetical", "http://cannassist.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r41", "r286" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock shares, authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheetsParenthetical", "http://cannassist.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r41", "r155" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r41", "r286", "r305", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "PREFERRED STOCK" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/PreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r41", "r240", "r358" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r28", "r41" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Preferred stock, voting rights", "verboseLabel": "Preferred stock voting rights" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative", "http://cannassist.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r88", "r139", "r140", "r350" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromBankDebt": { "auth_ref": [ "r14" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from bank borrowing during the year.", "label": "Proceeds from loans payable" } } }, "localname": "ProceedsFromBankDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r14" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from loans - related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyExpense": { "auth_ref": [ "r2", "r405" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.", "label": "Warrant expense" } } }, "localname": "ProductWarrantyExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r368", "r427", "r428" ], "calculation": { "http://cannassist.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r81", "r89", "r90", "r97", "r103", "r107", "r114", "r115", "r128", "r131", "r133", "r135", "r136", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r202", "r205", "r206", "r216", "r217", "r236", "r245", "r263", "r307", "r327", "r328", "r351", "r356", "r357", "r369", "r395", "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date of maturity or expiration of arrangements with a related party (for example, but not limited to, leasing and debt arrangements between related parties), in YYYY-MM-DD format.", "label": "Related Party Transaction, Date", "verboseLabel": "Maturity date" } } }, "localname": "RelatedPartyTransactionDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r226", "r227", "r228", "r229", "r230", "r260", "r261", "r262", "r311", "r312", "r313", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r44", "r61", "r242", "r252", "r253", "r259", "r287", "r358" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets", "http://cannassist.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r80", "r104", "r105", "r106", "r108", "r113", "r115", "r137", "r138", "r194", "r195", "r196", "r198", "r199", "r209", "r211", "r212", "r214", "r215", "r249", "r251", "r264", "r429" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of all information related to the key inputs and assumptions (including, at a minimum, but not limited to, and if applicable, quantitative information about discount rates, expected prepayments including the expected weighted-average life of prepayable financial assets, and anticipated credit losses) used in measuring the fair value of assets or liabilities that relate to the transferor's continuing involvement with transferred financial assets, as of the balance sheet date.", "label": "Options issued with the following inputs" } } }, "localname": "ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in common stock outstanding.", "label": "Schedule of common stock outstanding roll forward" } } }, "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r32", "r62" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative", "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r4", "r5", "r34" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of stock options activity number of shares" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r25", "r26", "r27", "r28", "r29", "r30", "r31", "r59", "r60", "r61", "r85", "r86", "r87", "r126", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r255", "r256", "r257", "r258", "r354", "r391", "r396" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).", "label": "Schedule of weighted average number of shares" } } }, "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r393", "r394", "r409" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets", "http://cannassist.com/role/BalanceSheetsParenthetical", "http://cannassist.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r2" ], "calculation": { "http://cannassist.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://cannassist.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows", "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Number of warrants outstanding, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/WarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r179", "r180" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of warrants outstanding outstanding at ending", "periodStartLabel": "Number of warrants outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/WarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r179", "r180" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted average exercise price at ending", "periodStartLabel": "Weighted average exercise price at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/WarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk Free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number of options exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted average exercise price exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of options, Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r171", "r172" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of options outstanding at ending", "periodStartLabel": "Number of options outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r171", "r172" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise pricec at ending", "periodStartLabel": "Weighted average exercise pricec at Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative", "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r55", "r102" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r79", "r85", "r86", "r87", "r103", "r119", "r120", "r123", "r124", "r126", "r127", "r136", "r145", "r147", "r148", "r149", "r152", "r153", "r155", "r156", "r158", "r159", "r161", "r217", "r255", "r256", "r257", "r258", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r276", "r286", "r308", "r329", "r342", "r343", "r344", "r345", "r346", "r391", "r396", "r401" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets", "http://cannassist.com/role/BalanceSheetsParenthetical", "http://cannassist.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r3", "r13", "r80", "r91", "r92", "r93", "r104", "r105", "r106", "r108", "r113", "r115", "r125", "r137", "r138", "r163", "r194", "r195", "r196", "r198", "r199", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r218", "r219", "r220", "r221", "r222", "r223", "r225", "r249", "r250", "r251", "r264", "r329" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r104", "r105", "r106", "r125", "r235", "r254", "r276", "r279", "r280", "r281", "r282", "r283", "r284", "r286", "r289", "r290", "r291", "r292", "r293", "r295", "r296", "r297", "r298", "r300", "r301", "r302", "r303", "r304", "r306", "r309", "r310", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r329", "r363" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets", "http://cannassist.com/role/BalanceSheetsParenthetical", "http://cannassist.com/role/OptionsDetails2", "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative", "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r104", "r105", "r106", "r125", "r235", "r254", "r276", "r279", "r280", "r281", "r282", "r283", "r284", "r286", "r289", "r290", "r291", "r292", "r293", "r295", "r296", "r297", "r298", "r300", "r301", "r302", "r303", "r304", "r306", "r309", "r310", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r329", "r363" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets", "http://cannassist.com/role/BalanceSheetsParenthetical", "http://cannassist.com/role/OptionsDetails2", "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative", "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock issued during period, value, issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r3", "r13", "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock option expense" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r3", "r41", "r42", "r61" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Number of shares cancelled" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r42", "r45", "r46", "r57", "r288", "r305", "r330", "r331", "r358", "r370", "r397", "r403", "r412", "r429" ], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets", "http://cannassist.com/role/StatementsOfChangesOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r22", "r23", "r24", "r72", "r73", "r75", "r76" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r360", "r361", "r364", "r365", "r366", "r367" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant term", "periodEndLabel": "Weighted average remaining contract term at ending", "periodStartLabel": "Weighted average remaining contract term at beginning", "terseLabel": "Weighted average remaining contractual life (years)", "verboseLabel": "Warrants and Rights Outstanding, Term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/OptionsDetails", "http://cannassist.com/role/OptionsDetails2", "http://cannassist.com/role/WarrantsDetails", "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r118", "r124" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average shares outstanding, basic and diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "xesp_ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average exercise price" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/OptionsDetails2", "http://cannassist.com/role/WarrantsDetails1" ], "xbrltype": "perShareItemType" }, "xesp_DisclosureNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable" } } }, "localname": "DisclosureNotesPayableAbstract", "nsuri": "http://cannassist.com/20230331", "xbrltype": "stringItemType" }, "xesp_DisclosureOptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options" } } }, "localname": "DisclosureOptionsAbstract", "nsuri": "http://cannassist.com/20230331", "xbrltype": "stringItemType" }, "xesp_DisclosureWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants" } } }, "localname": "DisclosureWarrantsAbstract", "nsuri": "http://cannassist.com/20230331", "xbrltype": "stringItemType" }, "xesp_DueFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Due from Related Parties" } } }, "localname": "DueFromRelatedParty", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "xesp_DueToRelatedParty": { "auth_ref": [], "calculation": { "http://cannassist.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Due to a related party", "verboseLabel": "Due to related party" } } }, "localname": "DueToRelatedParty", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/BalanceSheets", "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "xesp_Forty7SelectHoldingsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forty 7 Select Holdings L L C [Member]" } } }, "localname": "Forty7SelectHoldingsLLCMember", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "xesp_LossPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss per share, basic and diluted" } } }, "localname": "LossPerShareBasicAndDiluted", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "xesp_NotesPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTES PAYABLE" } } }, "localname": "NotesPayableTextBlock", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "xesp_NumberOfWarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrants exercisable (in shares)" } } }, "localname": "NumberOfWarrantsExercisable", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/WarrantsDetails" ], "xbrltype": "sharesItemType" }, "xesp_OptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options [Member]" } } }, "localname": "OptionsMember", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/OptionsDetails" ], "xbrltype": "domainItemType" }, "xesp_OptionsOutstandingGrantedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average remaining contract term, Granted" } } }, "localname": "OptionsOutstandingGrantedTerm", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "durationItemType" }, "xesp_OptionsOutstandingTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average remaining contract term at ending" } } }, "localname": "OptionsOutstandingTerm", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "durationItemType" }, "xesp_OptionsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPTIONS" } } }, "localname": "OptionsTextBlock", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/Options" ], "xbrltype": "textBlockItemType" }, "xesp_PhitechManagementLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Phitech Management L L C [Member]" } } }, "localname": "PhitechManagementLLCMember", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/DescriptionOfBusinessAndHistoryDetailsNarrative" ], "xbrltype": "domainItemType" }, "xesp_ScheduleOfCommonStockOptionsOutstandingRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of options activity" } } }, "localname": "ScheduleOfCommonStockOptionsOutstandingRollForwardTableTextBlock", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/OptionsTables" ], "xbrltype": "textBlockItemType" }, "xesp_SupplementalDisclosureOfNoncashActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash activity:" } } }, "localname": "SupplementalDisclosureOfNoncashActivityAbstract", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "xesp_ThirdParty1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Party 1 [Member]" } } }, "localname": "ThirdParty1Member", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "xesp_ThirdParty2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Party 2 [Member]" } } }, "localname": "ThirdParty2Member", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "xesp_ThirdParty3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Party 3 [Member]" } } }, "localname": "ThirdParty3Member", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "xesp_ThirdParty4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Party 4 [Member]" } } }, "localname": "ThirdParty4Member", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "xesp_ThirdParty5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Party 5 [Member]" } } }, "localname": "ThirdParty5Member", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "xesp_ThirdParty6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Party 6 [Member]" } } }, "localname": "ThirdParty6Member", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "xesp_WarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WARRANTS" } } }, "localname": "WarrantsTextBlock", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "xesp_WeightedAverageExercisePriceExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WeightedAverageExercisePriceExercisable", "verboseLabel": "Weighted average exercise price exercisable" } } }, "localname": "WeightedAverageExercisePriceExercisable", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/WarrantsDetails" ], "xbrltype": "perShareItemType" }, "xesp_WeightedAverageRemainingContractTermExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WeightedAverageRemainingContractTermExercisable", "verboseLabel": "Weighted average remaining contract term, exercisable" } } }, "localname": "WeightedAverageRemainingContractTermExercisable", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/WarrantsDetails" ], "xbrltype": "durationItemType" }, "xesp_WeightedAverageRemainingContractTermExercisable1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average remaining contract term, exercisable" } } }, "localname": "WeightedAverageRemainingContractTermExercisable1", "nsuri": "http://cannassist.com/20230331", "presentation": [ "http://cannassist.com/role/OptionsDetails1" ], "xbrltype": "durationItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r371": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r372": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r373": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r374": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r375": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r376": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r377": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r378": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r379": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r381": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r382": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r383": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r384": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r385": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r386": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r387": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r388": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r389": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r39": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org//205-40/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "83", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480647/815-10-15-83", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 46 0001214659-23-007091-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-23-007091-xbrl.zip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